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As many as 82% of children with Autism Spectrum Disorders (ASD) experience 
numerous chronic sleep-related problems and at a much higher frequency and severity 
than their typically developing peers. Behavioral treatments are considered best practice 
and first-line treatment to address sleep problems. These treatments tend to address one 
specific sleep-related behavior at a time. Bedtime Fading with Response Cost (BFRC) is 
a promising intervention that targets a multitude of sleep problems concurrently and has 
yet to be replicated by more than one investigative team in the home setting with children 
on the autism spectrum. This study evaluated the effectiveness of BFRC in decreasing 
sleep disturbances in children with ASD using parents as change agents by implementing 
treatment in the home environment. A non-concurrent multiple baseline design across 
three participants was used. Results indicate that BFRC was effective in eliminating 
unwanted co-sleeping, frequent night awakenings, and dependent sleep onset and 
reducing sleep onset latency, bedtime resistance, and disruptive sleep-related behaviors. 
Follow-up data demonstrate that gains were maintained. Parents reported high 
satisfaction with BFRC and sleep outcomes for their children. This study extends both the 
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practice and science of parent-implemented behavioral interventions as treatment options 
for children with ASD and co-occurring sleep problems. 
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Bedtime Fading with Response Cost for Treatment of Sleep Disturbances in Children 
with Autism Spectrum Disorder 
Introduction 
Background 
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder affecting one 
out of 68 children in the United States (Center for Disease Control and Prevention 
[CDC], 2016). ASD is characterized by core deficits in social communication and social 
interactions and atypical repetitive behaviors and restricted interests (American 
Psychiatric Association [APA], 2013; CDC, 2016; Reynolds & Malow, 2011). Sleep 
disturbance is one of the most common and challenging behaviors experienced by 
children with ASD (Dominick, Ornstein Davis, Lainhart, Tager-Flusberg, & Folstein, 
2007; Levin & Scher, 2016; Reynolds & Malow, 2011; Wiggs & Stores, 2004) and is 
frequently associated with co-occurring behavioral difficulties (Adams, Matson, & Jang, 
2014; Mazurek & Sohl, 2016). Prevalence rates of chronic sleep-related problems in 
children with ASD range from approximately 52% to 82% compared with 32% to 50% in 
children with typical development (Hodge, Carollo, Lewin, Hoffman, & Sweeney, 2014; 
Krakowiak, Goodlin-Jones, Hertz-Picciotto, Croen, & Hansen, 2008).   
Sleep disturbance is an umbrella term for a range of sleep-related problems 
presumably lacking an underlying medical basis, as opposed to sleep disorders. In the 
pediatric sleep literature, the sleep disturbance and sleep problems terms are often used 
interchangeably (Turner & Johnson, 2012) to refer to common parent-reported sleep 
concerns such as bedtime refusal, delayed sleep onset, frequent night awakenings, and 
undesired co-sleeping (Blampied & France, 1993). Parents of children with ASD report a 
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variety of disturbed sleep behaviors, such as reduced sleep duration, delayed sleep onset, 
early rising, excessive daytime sleep, lack of independent sleep initiation skills, frequent 
night waking, difficulty following bedtime routines and undesired co-sleeping 
(Christodulu & Durand, 2004; Durand, 2002; Knight & Johnson, 2014; Moon, Corkum, 
& Smith, 2010; Piazza, Fisher, & Sherer, 1997; Weiskop, Richdale, & Matthews, 2005). 
Notably, these particular sleep problems are not uniquely different than those reported by 
parents of typically developing children. It is clear, however, that children with ASD are 
affected by disrupted sleep at a much higher frequency and with a much greater severity 
than their typically developing peers (Anders, Iosif, Schwichtenberg, Tang & Goodlin-
Jones, 2011; Hodge, Carollo, Lewin, Hoffman, & Sweeney, 2014; Krakowiak, Goodlin-
Jones, Hertz-Picciotto, Croen, & Hansen, 2008; Owens & Whitmans, 2004). 
Parents’ report that their child’s sleep problems exacerbate difficulties with social 
functioning, mood, and fatigue (Lopez-Wagner, Hoffman, Sweeney, Hodge, & Gilliam, 
2008), which may, in turn, decrease the child’s quality of life and limit independent 
functioning. Sleep problems in children with ASD can also have detrimental effects on 
the entire household (Patzold, Richdale, & Tonge, 1998; Tilford, et al., 2015). When 
children do not sleep, it often means that their siblings and parents do not sleep, either. 
Parents of children with ASD who sleep poorly during the previous night are likely to 
have an increased negative affect/decreased positive affect the following day (Mihaila & 
Hartley, 2016). Additionally, mothers who experience chronic poor sleep perceive their 
child’s behavior problems as occurring at a higher frequency and severity and/or their 
own parenting skills as less effective (Mihaila & Hartley, 2016). 
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Parents of children with ASD experience higher levels of stress and depression 
and lower levels of marital intimacy than parents of children with and without other 
disabilities (Fisman, Wolf, & Noh, 1989; Levin & Scher, 2016; Tilford, et al., 2015). 
Parents of children with ASD report a lack of time for family activities, recreation, and 
for each other, which can negatively impact the quality of marriage (Fisman, Wolf, & 
Noh, 1989). This may explain why sleep disturbances experienced by children with ASD 
often result in increased family stress, marital discord, and decreased parental intimacy 
(Goodlin-Jones, Tang, Liu, & Anders, 2008; Fisman, Wolf, & Noh, 1989; Hoffman, et. 
al., 2008; Mihaila & Hartley, 2016; Meltzer, 2011; Patzold, Richdale, & Tonge, 1998; 
Piazza & Fisher, 1991b; Tilford, et al., 2015).  
Treatment 
Pharmacological agents in conjunction with behavioral intervention are often 
recommended for the treatment of sleep disturbance in children with ASD (Johnson & 
Malow, 2008). Medications prescribed to children with ASD to treat sleep disturbance 
include synthetic melatonin, benzodiazepines, clonidine, beta-blockers, as well as 
antipsychotics as a means to counter undesired motor effects (Murray, et. al., 2014). 
Melatonin is a naturally occurring hormone released by the pineal gland to help promote 
and maintain the circadian rhythm. Synthetically derived melatonin is widely available in 
the United States as an over-the-counter supplement (Bramble & Feehan, 2005) and is 
used as a first-line treatment for promoting sleep in children on the autism spectrum 
(Malow & McGrew, 2008).  
To date, the use of behavioral principles (Jin, Hanley, & Beauliue, 2013; Knight 
& Johnson, 2014; Turner & Johnson, 2012; Vriend, Corkum, Moon, & Smith, 2011) or 
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melatonin (Malow, et al., 2012; Rossignol & Frye, 2011) to address behavioral sleep 
disturbances in children with ASD has been explored in 16 and 10 studies, respectively. 
Of the melatonin studies, two represent retrospective reviews of records (Andersen, 
Kaczmarska, McGrew, & Malow, 2008; Gupta & Hutchins, 2005) and six combine the 
implementation of behavioral principles with the delivery of melatonin (Garstang & 
Wallis, 2006; Giannotti, Cortesi, Cerquiglini, & Bernabei, 2006; Malow, et al., 2012; 
Paavonen, Nieminen-von Wendt, Vanhala, Aronen, & von Wendt, 2003; Wasdell, et. al., 
2008; Wright, et. al., 2010). Only two studies have evaluated melatonin administration 
alone without concomitant use of behavioral methods, and one of them is a brief case 
study (Jan, Freeman, Wasdell, & Bomben, 2004; Wirojanan, et. al., 2009).  
Melatonin has been shown to improve sleep outcomes in children with ASD by 
reducing sleep onset latency (Dodge & Wilson, 2001), and increasing total sleep time 
(Wirojanan, et. al., 2009). The sustainability of such benefits, once the medication is 
withdrawn, has yet to be evaluated. Research results indicate that melatonin does not 
have an effect on the parental concerns of frequency of night awakenings (Dodge & 
Wilson, 2001; Wirojanan, et al., 2009). Moreover, lacking is the evaluation of melatonin 
as a treatment option for other disruptive sleep behaviors that parents have identified as 
their primary concern (e.g., bedtime resistance and undesired co-sleeping) (Christodulu & 
Durand, 2004; Weiskop, Matthews, & Richdale, 2001; Weiskop, Richdale, & Matthews 
2005).  
At this time, there is no established dosage or recommended length of use of 
melatonin in addressing sleep problems in children with ASD (Kennaway, 2015; Malow, 
et al., 2012; Rossignol & Frye, 2011). Some children with ASD may experience poor 
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metabolism and disappearing effects of melatonin, leading to potential dose escalation 
(Braam, et al., 2012). Similar to other pharmacological agents, melatonin falls short for 
many parents because taking a medication does not teach healthy sleep behaviors to 
ensure lasting change (Malow & McGrew, 2008). Therefore, research on the exclusive 
use of melatonin to improve sleep disturbances in children, with and without ASD, 
remains limited and needs to be more rigorously evaluated (Kennaway, 2015).  
In the field of behavioral sleep medicine, interventions are based on the principles 
of learning that employ methods of reinforcement, contingency management, shaping, 
and extinction to teach healthy and appropriate sleep behaviors that last a lifetime. 
Interventions with a validated body of research to support their utility, referred to as 
empirically supported treatments (ESTs), are considered first-line treatments in 
behavioral sleep medicine. The ‘gold standard’ criteria for determining the validity of 
such interventions were first established by members of the American Psychological 
Association Division 12 task force (Chambless & Ollendick, 2001). These criteria 
include definitions of  “well established”, “probably efficacious”, and “promising” 
interventions, which function as guidelines for determining and choosing the best 
available ESTs (Chambless, Baker, Baucom, Beutler, Calhoun, Crits-Christoph, et al. 
1998; Chambless & Hollon, 1998; Powers, 1999).  
Behavior-based treatments are considered best practice in addressing sleep 
problems in typically developing children due to significant improvements experienced 
by 80% of children treated (Mindell, Kuhn, Lewin, Meltzer, & Sadeh, 2006). At this 
time, research indicates that behavioral interventions for the treatment of sleep problems 
in children with ASD have yet to be classified as well established or probably efficacious 
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(Schreck, 2001; Vriend, Corkum, Moon, & Smith, 2011). This may be due to insufficient 
methodological rigor, lack of significant or equivalent outcomes, and/or the absence of 
duplicated studies by more than one investigator or research group that is needed to meet 
classification requirements.   
Behavioral interventions addressing sleep problems in children with ASD include 
bedtime routine (Piazza, Fisher, & Sherer, 1997; Weiskop, Richdale, & Matthews, 2005); 
extinction (Durand, Gernert-Dott, & Mapstone, 1996; Weiskop, Matthews, & Richdale, 
2001; Wolf, Risley, & Mees, 1964); scheduled awakenings (Durand, 2002); sleep 
restriction (Christodulu & Durand, 2004; Durand & Christodulu, 2004); stimulus fading 
(Christodulu & Durand, 2004; Howlin, 1984); chronotherapy (Piazza, Hagopian, Hughes, 
& Fisher, 1998); parent education (Malow, et al., 2014; Moon, Corkum, & Smith, 2010; 
Weiskop, Matthews, & Richdale, 2001); bedtime fading with (Moon, Corkum, & Smith, 
2010; Piazza, Fisher, & Sherer, 1997) and without response cost (DeLeon, Fisher, & 
Marhefka, 2004); as well as multi-component treatment packages (Jin, Hanley, & 
Beauliue, 2013; Knight & Johnson, 2014; Montgomery, Stores, & Wiggs, 2004; Reed, et 
al., 2009). Among behavioral interventions, most tend to address one specific sleep-
related behavior at a time (Piazza & Fisher, 1991b), such as night terrors (Durand, 2002); 
disrupted sleep-wake cycle (Piazza, Hagopian, Hughes, & Fisher, 1998), and excessive 
daytime sleepiness (Friedman & Luiselli, 2008). In reality, parents of children with ASD 
tend to report a multitude of co-occurring sleep problems (e.g., bedtime resistance, 
delayed sleep onset, frequent night waking, and undesired co-sleeping) (Christodulu & 
Durand, 2004; Durand & Christodulu, 2004; Durand, Gernert-Dott, & Mapstone, 1996; 
Reed, et. al., 2009; Weiskop, Matthews, & Richdale, 2001). 
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Parents of children with ASD report that some sleep disturbances evolve from 
their own attempts to address other long-standing sleep problems, such as engaging in 
undesired co-sleeping to reduce night awakenings (Reed, et al., 2009). Undesired co-
sleeping can be a part of the initial bedtime routine (Weiskop, Matthews, & Richdale, 
2001; Weiskop, Richdale, & Matthews, 2005) or a response to difficulty falling back 
asleep and disruptive behaviors (i.e., tantrums, refusal to sleep in own bed, or escaping 
from the bed and bedroom) following night awakenings (Christodulu & Durand, 2004; 
Durand & Christodulu, 2004; Durand, Gernert-Dott, & Mapstone, 1996; Howlin, 1984). 
Therefore, it is not surprising that undesired co-sleeping experienced by children with 
ASD often coincides with a wide variety of sleep problems, including frequent night 
awakenings, bedtime disturbances, difficulty falling asleep and reinitiating sleep 
independently, decreased duration of sleep, early morning awakenings, and refusal to 
sleep in one’s own bed (Christodulu & Durand, 2004; Durand & Christodulu, 2004; 
Durand, Gernert-Dott, & Mapstone, 1996; Howlin, 1984; Reed, et. al., 2009; Weiskop, 
Matthews, & Richdale, 2001; Weiskop, Richdale, & Matthews, 2005).    
Bedtime Fading with Response Cost (BFRC) is a promising behavior-based 
intervention that targets a multitude of sleep problems concurrently (Piazza, Fisher, & 
Sherer, 1997). Specifically, BFRC has been demonstrated to decrease disruptive sleep-
related behaviors, reduce sleep latency, reduce night awakenings, and increase sleep 
duration in children with ASD (DeLeon, Fisher, & Marhefka, 2004; Moon, Corkum, & 
Smith, 2010; Piazza, Fisher, & Moser, 1991; Piazza, Fisher, & Sherer, 1997). BFRC has 
also been effective in reducing (Piazza & Fisher, 1991b; Piazza, Fisher, & Moser, 1991) 
and even eliminating (Ashbaugh & Peck, 1998) undesired co-sleeping in children without 
BEDTIME FADING WITH RESPONSE COST  11    11  
 
 
ASD. Thus far, undesired co-sleeping has not been the primary sleep variable in studies 
evaluating BFRC with children on the autism spectrum. To date, undesired co-sleeping 
has been used as the primary dependent variable in only two studies (Weiskop, 
Matthews, & Richdale, 2001; Weiskop, Richdale, & Matthews, 2005) in children with 
ASD. Both studies focused on parent-defined sleep disturbances and treatment goals. 
Original BFRC Protocol   
BFRC involves temporarily delaying the child’s typical bedtime, establishing a 
set wake-time (regardless of the amount of sleep acquired the night before), and 
eliminating access to daytime sleep (for non-napping children ages 4 and older) (Piazza 
& Fisher, 1991b). Developmental sleep norms in conjunction with parent sleep goals are 
used to set the appropriate bedtime and wake-time based on the amount of sleep required 
for each child. Parents are informed of the average hours of sleep per night needed by 
their child according to his or her chronological age and asked to indicate their preferred 
time of sleep onset, awakening, and nap (if applicable). The original BFRC protocol 
began with collecting baseline data on whether the child was asleep or awake every 30 
minutes, throughout a 24-hour period, until data were determined stable. Once baseline 
data are stable, the child’s mean sleep onset time was calculated and the child’s bedtime 
was temporarily delayed by adding 30 minutes to the average time the child typically fell 
asleep (i.e., faded bedtime) (Piazza & Fisher, 1991b). For example, if the child’s average 
time of sleep onset was10:45 p.m. during baseline, the initial bedtime was set to 
11:15pm.  
 The caregivers placed the child in bed at the scheduled bedtime and observed the 
child 15 minutes later to determine whether the child was asleep or awake. A caregiver 
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stood within one foot of the child and whispered his or her name. If the child did not 
respond to his or her name (i.e., the absence of motor or verbal response), then the child 
was considered to be asleep, and the caregiver recorded the time of sleep onset. If the 
child was not asleep, he or she was removed from his or her bed, and restrict access to the 
bed, bedroom, and sleep for 45 minutes (i.e., response cost). During that time, the child 
was allowed to partake in regular nighttime activities (e.g., play with toys, watch TV) not 
related to sleep. At the end of the 45 minutes the child was returned to bed. If the child 
did not fall asleep within 15 minutes of being returned to bed, the caregivers repeated the 
response cost procedure by removing the child from bed for 45 minutes and allowed the 
child to engage in non-sleep related activities. This procedure was repeated until the child 
fell asleep within 15 minutes of being placed in bed (Piazza & Fisher, 1991b).  
 Each subsequent night the child’s bedtime was adjusted by 30 minutes based on 
the time of sleep onset during the previous night. For example, if bedtime was 10:30 
p.m., and the child did not fall asleep until 12:00 a.m., the following night the bedtime 
would be 11:00 p.m.; similarly, if the child fell asleep at 10:30 p.m., the following night 
the bedtime would be adjusted to 10:00 p.m. For instances of nighttime awakenings, 
caregivers were encouraged to prompt the child to return to his or her bed every 30 
minutes. Caregivers allowed the child to engage in regular nighttime activities. The 
predetermined wake-time was strongly enforced by the caregivers every day, regardless 
of the amount and quality of the child’s sleep during the previous night. Caregivers 
eliminated access to daytime sleep, unless naps were appropriate for the age and 
developmental needs of the child (Piazza & Fisher, 1991b).   
BFRC Procedural Variants 
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Modifications to the original BFRC protocol have been reported in subsequent 
studies (Ashbaugh & Peck, 1998; DeLeon, Fisher, & Marhefka, 2004; Moon, Corkum, & 
Smith, 2010; Piazza, Fisher, & Sherer, 1997). Variations include the amount of time the 
bedtime is faded, the duration of time allowed to achieve sleep before response cost is 
implemented, the duration of the response cost procedure itself, and the duration of faded 
bedtime. The amount of time added to the faded bedtime and the duration of response 
cost, i.e., time spent out of bed when not achieving sleep onset, have been evaluated 
using both 30- and 60-minute intervals. The amount of time allotted between placing a 
child in bed and checking sleep onset has included both 15- and 20-minute intervals. 
Fading the bedtime once sleep onset is achieved has been evaluated with both 15- and 30-
minute intervals and after either one or two consecutive nights. In addition, the original 
authors of BFRC suggest fading the bedtime by 15 minutes, rather than 30 minutes, if the 
child’s bedtime fading plateaus (does not progress) before reaching the bedtime goal 
(Piazza & Fisher, 1991b). With and without modifications to the original protocol, BFRC 
has been shown to be effective in addressing various co-occurring sleep disturbances with 
a typically developing child (Ashbaugh & Peck, 1998), children with intellectual 
disability (ID) (Piazza & Fisher, 1991b), children with autism (DeLeon, Fisher, & 
Marhefka, 2004; Moon, Corkum, & Smith, 2010; Piazza, Fisher, & Sherer, 1997) and 
related disorders (Piazza, Fisher, & Moser, 1991).    
BFRC and Children with Non-ASD Neurodevelopmental Disorders 
 The bedtime fading procedure without the response cost component was first 
developed by Piazza and Fisher (1991a) to increase the duration of appropriate nighttime 
sleep of two children with severe sleep problems. Treatment included utilizing baseline 
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data of each participant’s average time (i.e., within 15 minutes) of sleep onset that was 
most likely to occur. Faded bedtime was then determined by calculating the baseline 
average for sleep onset and adding one half hour. For example, if the average sleep onset 
time is 10:00 p.m. during baseline, then the initial bedtime during the treatment phase is 
10:30 p.m. Treatment required the child to remain awake until the faded bedtime and 
access to the bed was not permitted until the designated bedtime. Additionally, a 
predetermined wake time was established and the participant was not allowed to sleep 
past this time (Piazza & Fisher, 1991a). Based on the previous night’s time of sleep onset, 
the bedtime was adjusted accordingly, such that if the child fell asleep within 15 minutes 
of the designated bedtime, the bedtime was adjusted 15 minutes earlier. Correspondingly, 
if the child did not fall asleep within the allotted 15 minutes, the bedtime was pushed 
later an additional 15 minutes. Bedtime adjustment required two consecutive nights of the 
same established sleep onset time before fading the bedtime on the third night.   
Two participants, a 6-year-old female diagnosed with attention deficit-
hyperactivity disorder (ADHD) and a 4-year-old female diagnosed with profound ID and 
comorbid tuberous sclerosis were included in the study (Piazza & Fisher, 1991a). Both 
participants experienced multiple sleep problems, including bedtime refusal, bedtime 
disruption, and a lack of independent sleep initiation. The 6-year-old participant 
experienced frequent night awakenings and obtained only four to six hours of sleep per 
night. Treatment was initiated while the participant lived at home with her grandmother. 
The 4-year-old participant experienced excessive daytime sleepiness and fell asleep 
multiple times during the day. Treatment was conducted while the participant resided at 
an inpatient facility for children with developmental disabilities. A momentary time 
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sampling procedure (every 30 minutes during a 24-hour cycle) was utilized to record 
whether the child was in or out of bed and awake or asleep. Trained observers collected 
data on the participant in the inpatient unit. The grandmother of the in-home participant 
collected data until she went to bed, with the addition of two scheduled checks at 2:00 
a.m. and 4:00 a.m. (Piazza & Fisher, 1991a).   
Results indicate that bedtime fading procedure increased the percentage of 
appropriate sleep (i.e., hours of sleep occurring within the determined timeframe) and 
increased the duration of sleep for both participants. In addition, bedtime fading 
eliminated the problem sleep behaviors of night awakening and bedtime refusal for the 6-
year-old participant. The authors suggested that bedtime fading is potentially useful for 
combating multiple sleep problem concurrently as it may help to institute a consistent 
sleep cycle and establish the bed as a conditioned reinforcer for sleep (Piazza & Fisher, 
1991a). One limitation of the study was that the authors did not use an objective measure 
(e.g., actigraphy) of the participants’ target behaviors. Skill acquisition and the 
elimination of problem sleep behaviors were based on observers’ and caregiver reports.  
The same authors were the first to evaluate bedtime fading with the added 
component of response cost (BFRC) (Piazza & Fisher, 1991b). The additional treatment 
component included removing the child from bed and keeping him or her awake for one 
hour if sleep was not initiated within 15 minutes of the initial bedtime. During the hour of 
response cost, the child was permitted access to the same items and attention as found 
during baseline. At the end of the one-hour interval, the child was returned to bed and 
allowed 15 minutes to fall asleep. If the child did not fall asleep within the allotted 
amount of time, he or she was removed from the bed again (i.e., response cost) and 
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required to remain awake for an additional hour. The outlined procedure was repeated 
until sleep onset was achieved within 15 minutes of being placed in bed. The 
investigators hypothesized that the response cost component would “enhance treatment 
efficacy” by allowing for “a more rapid fading of the bedtime”, thus increasing the 
reinforcing value of sleep (Piazza & Fisher, 1991b).  
Participants were four nonverbal children diagnosed with profound ID and living 
in an inpatient unit for the treatment of ID and self-injurious behaviors. All participants 
experienced co-occurring sleep problems such as delayed sleep onset, inconsistent sleep 
duration, night awakenings, early morning awakenings, disruptive bedtime behaviors, 
and excessive daytime sleep, whereas one participant experienced undesired co-sleeping. 
Similarly to the first bedtime fading study (Piazza & Fisher, 1991a), the investigators 
employed a momentary time-sampling (e.g., each half hour) method conducted by trained 
observers to record whether or not the participants were in or out of bed and awake or 
asleep. The effectiveness of the procedure was evaluated using a non-concurrent multiple 
baseline across subjects. The parameters for the bedtime fading component as found in 
the preliminary study were used in the same manner, with the response cost component 
previously described (Piazza & Fisher, 1991b). 
Two different observers scored the child’s behavior (i.e., awake or asleep, in or 
out of bed) to assess inter-observer agreement (IOA). Results of the study indicated that 
all participants either improved in the percentage of intervals of appropriate sleep or 
decreased in the percentage of intervals of inappropriate sleep. Three out of four 
participants demonstrated a decrease in the frequency of night awakenings. Furthermore, 
disruptive bedtime behaviors decreased from 100% to 16% for one participant and 
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undesired co-sleeping decreased by nearly 50% for another. The authors concluded that 
each participant benefited from the BFRC procedure and that both classical and operant 
conditioning may have facilitated treatment efficacy (Piazza & Fisher, 1991b).   
A third study, coauthored by Piazza, Fisher, & Moser (1991), sought to evaluate 
whether BFRC would be effective in improving the aberrant sleep patterns of three girls 
with Rett Syndrome (RS). Standard BFRC procedures were used for all three participants 
who were participating in inpatient (N=2) or outpatient (N=1) services for the treatment 
of behavior problems. Sleep problems included night awakenings, unwanted co-sleeping, 
delayed sleep onset, and excessive daytime sleep. Data recording methods and IOA 
employed by the trained observers and parent participants remained consistent with 
methods outlined in previous studies (Piazza & Fisher, 1991a; Piazza & Fisher, 1991b).  
Results demonstrated an increase in the percentage of appropriate sleep for all 
participants, although clinical significance was not determined (Piazza, Fisher, & Moser, 
1991). In addition, time of sleep onset decreased for one participant, and the duration of 
night awakenings, as well as the percentage of daytime sleep, decreased for two 
participants. Outcomes for undesired co-sleeping were not directly reported, although the 
authors did indicate that the parents of one participant were engaging in co-sleeping less 
frequently and spending less time soothing their child back to sleep. Similarly to the 
previous bedtime fading and BFRC studies (Piazza & Fisher, 1991a; Piazza & Fisher, 
1991b), no information was provided on how the parent participants were trained to 
implement the BFRC procedure or collect data on the observable sleep variables (Piazza, 
Fisher, & Moser, 1991). In addition, sleep variables were not measured objectively.  
BFRC and Typically Developing Children 
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 To date, only one study replicated the BFRC procedures with a typically 
developing child. Ashbaugh and Peck (1998) employed an ABAB experimental design 
with a typically developing 2-year-old female experiencing frequent night awakenings, 
disrupted sleep, and undesired co-sleeping. The participant lived at home with her 
biological father and mother, the latter being a member of the investigative team. 
Ashbaugh and Peck (1998) followed the BFRC protocol and data collection procedures 
as presented in the Piazza and Fisher (1991b) study, with two minor modifications: 1) 
The procedure included returning the child to her own bed if she awoke during the night, 
as requested by her parents; and 2) The response cost component was reduced from 1 
hour to 30 minutes. Bedtime for the subsequent night was adjusted earlier by 30 minutes 
if the child was able to fall asleep within the allotted 15 minutes or later by 30 minutes if 
the child was not able to fall asleep within 15 minutes of bedtime (Ashbaugh & Peck, 
1998). Parent and teacher observations of napping behavior were conducted and 
compared for IOA. Results of the study indicated that the participant was able to establish 
a more regular sleep schedule and undesirable co-sleeping was eliminated. The authors 
noted that slight modifications to the BFRC might not diminish the effectiveness of the 
intervention (Ashbaugh & Peck, 1998).  
BFRC and Children with ASD 
Three studies have evaluated the effects of BFRC in children with autism and 
sleep disturbance (DeLeon, Fisher, & Marhefka, 2004; Moon, Corkum, & Smith, 2010; 
Piazza, Fisher, & Sherer, 1997). All three studies concluded that faded bedtime, with or 
without response cost, was successful in improving sleep problems in children with 
autism. Piazza, Fisher, and Sherer (1997) compared the relative effectiveness of BFRC to 
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simple bedtime scheduling, which involved establishing a set bedtime and wake time 
(naps if age appropriate) and permitting sleep only during designated times. Bedtime 
scheduling also included implementing a consistent bedtime routine and placing the child 
in bed at the designated times (Piazza, Fisher, & Sherer, 1997). Five of the fourteen 
participants, ages 5 to 8 years, were diagnosed with ASD. Participants were randomly 
assigned to either the BFRC or the bedtime scheduling group. Treatment took place in an 
institutionalized setting as all 14 participants were being treated for severe behaviors in 
an inpatient unit (Piazza, Fisher, & Sherer, 1997). 
Sleep problems experienced by the sample population included early awakenings, 
difficulties initiating sleep independently, delayed sleep onset, and nighttime awakenings. 
BFRC procedures, data collections methods, and IOA techniques were adopted from 
previously described studies (Piazza & Fisher, 1991b; Piazza, Fisher, & Moser, 1991).  
Result indicated that for all participants the BFRC intervention, compared with bedtime 
scheduling, produced a greater reduction of sleep problems (Piazza, Fisher, & Sherer, 
1997). Of the two children with ASD in the bedtime scheduling group, one showed slight 
improvement with night waking and falling asleep, while the other child’s sleep problems 
(i.e., night awakening and early awakening) maintained at baseline levels. All three of the 
participants with ASD in the BFRC group demonstrated improvements with the near 
elimination of early awakenings and a decrease in the duration and frequency of night 
awakenings. Outcomes were maintained at a 4-month follow-up. Strength of this study 
was the inclusion of a comparison group to demonstrate the effectiveness of BFRC.  
A subsequent study evaluated the effectiveness of the faded bedtime component 
without response cost in solving sleep problems and preventing self-injurious behaviors 
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(SIBs) in a 4-year-old male with ASD (DeLeon, Fisher, & Marhefka, 2004). The 
participant awoke frequently throughout the night and engaged in head banging, flopping 
on the floor, and body hitting, until receiving contingent reinforcement of attention in the 
form of hugs and comfort. Treatment was conducted in an inpatient unit for the treatment 
of severe SIBs. BFRC treatment procedures, data collection methods, and IOA criteria 
were replicated from previous studies (Piazza & Fisher, 1991b; Piazza, Fisher, & Moser, 
1991; Piazza, Fisher, & Sherer, 1997). The investigators employed an AB design without 
a reversal condition due to the severe nature of the participants’ SIBs. Results 
demonstrated a decrease in the total number of night awakenings, which, in turn, lead to 
the reduction in the frequency and rate of the wake-related SIBs displayed by the 
participant (DeLeon, Fisher, & Marhefka, 2004).  
The most recent BFRC study examined the effectiveness of a manualized BFRC 
program in the reduction of problem sleep behaviors in children with ASD (Moon, 
Corkum, & Smith, 2010). All participants (N=3) had a diagnosis of ASD, lived at home 
with their biological families, and experienced delayed sleep onset and difficulties with 
initiating sleep. The parents of all participants were trained to provide the BFRC 
procedure at home. Each parent received a handbook on the treatment of sleep 
difficulties, including information on the principles of sleep hygiene, importance of 
consistent bedtime routines, and behavioral strategies for managing child’s daytime and 
sleep-related behaviors. Parents met with a therapist for 5 consecutive weeks to review 
the information provided in the handbook. In addition, at the end of each week, the 
therapist contacted parents by phone to review the content of the materials learned and to 
monitor progress (Moon, Corkum, & Smith, 2010).   
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The BFRC procedure, data collection method, and IOA criteria remained the 
same as described in preceding studies (Piazza & Fisher, 1991b; Piazza, Fisher, & Moser, 
1991; Piazza, Fisher, & Sherer, 1997) with minor exceptions: The duration of time 
allowed to attain sleep onset was increased from 15 minutes to 20 minutes (Moon, 
Corkum, & Smith, 2010). Sleep diaries and actigraphy were used to record sleep 
outcomes. Results indicate a reduction in sleep onset latency for all three participants. 
Outcomes were maintained at a 12-week follow-up, and parents reported satisfaction with 
the intervention. Strengths of this study include objective recording of sleep variables 
(i.e., actigraphy), clear use of behavioral definitions needed to replicate the study, and 
engaging parents to implement the BFRC protocol in the home environment (Moon, 
Corkum, & Smith, 2010). A weakness of the study is that it is impossible to isolate BFRC 
as the only independent variable when the intervention was presented in combination of 
other treatment strategies, such as the didactic sessions and handbook on behavioral 
strategies. As a result, the study makes it difficult to determine if treatment outcomes are 
the result of the BFRC intervention itself.  
Conclusion and Future Directions 
In summary, children with ASD experience various co-occurring sleep problems 
and disruptive sleep-related behaviors at a greater frequency and severity than typically 
developing children. Consequently, in children with ASD and their families quality of life 
and day-to-day functioning suffer. Parents of children with ASD who also experience 
sleep disturbances are especially at risk for mood disorders and marital dissatisfaction. 
Effective behavioral treatments that parents can reliably implement at home are limited. 
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BFRC is a promising intervention that successfully addresses sleep problems and sleep-
related problem behaviors in children with and without ASD.  
At this time, BFRC has been restricted to controlled studies by several groups of 
investigators implemented by trained professionals in institution settings. Consideration 
has yet to be given to how parents uniquely define sleep disturbance within the context of 
their own home and family. Primary sleep variables tend to be researcher defined, which 
may not capture the most salient aspects of a child’s sleep disturbances from the parent’s 
perspective. For example, undesired co-sleeping is a commonly occurring sleep 
disturbance reported by parents of children with ASD. However, parent-defined primary 
dependent variables have not been considered in any of the existing BFRC studies. Only 
one BFRC study engaged parents in implementing treatment of sleep problems in 
children with ASD in the home setting. However, none of these studies utilized parent-
derived sleep goals to determine the onset of treatment or evaluate the effectiveness of 
BFRC for the reduction of sleep disturbance in children with ASD. Therefore, the 
primary purpose of this study was to evaluate the effectiveness of BFRC as a parent-
implemented home-based treatment for parent-defined sleep disturbances and related 
sleep problems experienced by their child with ASD.  
Method 
Participants 
Children between ages 4 and 8 years with a clinical diagnosis of autism and sleep 
disturbance were recruited through a day treatment program for children with ASDs and 
an outpatient behavioral health clinic located in the Midwest. Participant recruitment 
continued until a sufficient number of eligible participants (N=3) needed for a single 
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subject research design was recruited. Participant selection criteria were adapted from 
other studies in the area of behavioral treatment of sleep disturbance in children (Mindell 
& Durand, 1993; Weiskop, Richdale, & Matthews, 2005). Recruited participants had a 
confirmed diagnosis of autism based on the Autism Diagnostic Observation Schedule, 
Second Edition (ADOS-2) (Lord, et al. 2012) and the Childhood Autism Rating Scale, 
Second Edition (CARS-2) (Schopler, Van Bourgondien, Wellman, & Love, 2010), which 
is standard practice in diagnostics. For the purposes of this study, individuals with a 
classification of Autism or Autism Spectrum on the ADOS-2, in combination with a 
classification of either Severe or Mild-to-Moderate on the CARS-2, met the criteria for a 
diagnosis of autism and were deemed eligible for participation in the study. Individuals 
classified as Non-Spectrum on the ADOS-2 and/or Minimal-to-No-Symptoms on the 
CARS-2 were excluded from the study. Eligible participants were required to be living at 
home with at least one parent at the time of the study and present with a minimum of 
four-week history of childhood sleep disturbances as denoted by 
▪ resistance to going to bed, defined as one or more verbal protests and/or 
physical protests a night, for a minimum of three nights per week; or 
▪ delayed sleep onset, defined as more than 20 minutes between bedtime and 
falling asleep, for a minimum of three nights per week; or 
▪ any of the following situations at bedtime for a minimum of three nights per 
week: 
• undesired co-sleeping with a parent or sibling, being rocked or held to 
fall asleep, falling asleep in a location other than his/her own bed; or 
• falling asleep with a bottle or pacifier; or 
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• spontaneous awakening that requires parental intervention to return to 
sleep at least once per night, at least three times per week.   
Children using pharmacological agents to regulate sleep and/or other behaviors 
were not necessarily excluded. Unless medically necessary, parents were asked to 
attempt to maintain their child’s medication regiment throughout the duration of 
the study. Excluded from the study were families who had received professionally 
derived information directly from a psychologist, therapist, and/or physician 
and/or used a behavior-based intervention to address their child’s sleep problems 
within the past 6 months (Moon, Corkum, & Smith, 2010).   
Three potential participants were screened and met criteria for participation. All 
three parents-child dyads enrolled and completed the study. All three children had been 
diagnosed with ASD prior to enrolling in the study.  Each participant met the 
classification of Autism on the ADOS-2 and the Severe Symptoms of Autism Spectrum 
Disorder group on the CARS-2 measures. All names were changed to protect 
participants’ right to confidentiality. Participant 1, Bill, was a 7-year-old Caucasian male 
attending the 1st grade. Bill’s parents reported that he exhibited bedtime resistance, 
refused to sleep in his own bed, and took longer than 20 minutes to fall asleep each night. 
He woke repeatedly throughout the night and each time sought parental presence to 
reinitiate sleep by crawling into his parents’ bed. His parents often engaged in undesired 
co-sleeping with Bill in their bed, as they were asleep when he crawled into their bed and 
remained asleep with Bill in bed. Participant 2, Holly, was an 8-year-old Caucasian 
female attending the 3rd grade. Her parents reported that she refused to sleep in her own 
bed and never fell asleep without parental presence. A parent had to remain next to Holly 
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each night in their bed and engaged in undesired co-sleeping to get her to fall asleep. 
Participant 3, Keith, was a 4-year-old Caucasian male attending preschool. His parents 
reported that he resisted bedtime, had difficultly falling asleep, and experienced frequent 
awakenings throughout the night. Keith required parental presence to fall asleep at 
bedtime and following any night awakening, which resulted in undesired co-sleeping in 
either his bed or his parents’ bed. His parents reported that Keith sometimes stayed 
awake throughout the entire night. 
All children were living with their biological parents and siblings. Each parent 
reported participating in implementing the BFRC protocol, whereas one designated 
parent from each dyad was responsible for collecting data and taking telephone calls from 
a member of the investigative team. During the study, all children continued their 
previously prescribed regiment of medication (Bill: dexmethylphenidate [Focalin], 
guanfacine, and melatonin; Holly: risperidone and melatonin; Keith: cetirizine [Zyrtec]). 
Table 1 provides a summary of participant characteristics including chronological age, 
gender, ADOS-2 scores and classification, CARS-2 scores and severity group, and sleep 
problems meeting selection criteria. 
Materials 
A trained clinician administered the ADOS-2 and CARS-2 to evaluate each child’s 
verbal, social, and cognitive abilities (Gotham, Risi, Pickles, & Lord, 2007). The ADOS-2 
is a semi-structured, standardized assessment for children ages 12 months through 
adulthood that allowed the examiner to observe and rate behaviors related to 
communication and social interaction and play skills identified as important to the 
diagnosis of ASD. Scores based on the examiner’s observations were calculated through 
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the use of a diagnostic algorithm to yield one of three classifications (i.e., Autism, Autism 
Spectrum, and Non-spectrum) (Lord, et al., 2012).  The use of the ADOS-2 alone does not 
provide justification for a diagnosis of ASD; therefore, the CARS-2 was used as a 
screening tool to compliment ADOS-2 outcomes.  
The CARS-2 is a valid and reliable clinician- and parent-completed rating scale 
for children ages 2-13 years (Schopler, Van Bourgondien, Wellman, & Love, 2010). The 
CARS-2 is comprised of descriptors of childhood social, developmental, and motor 
abilities related to ASD symptoms. A total score classifies children into one of three 
severity groups of ASD symptoms (i.e., Severe, Mild-to-Moderate, and Minimal-to-No-
Symptoms).   
Dependent measures of sleep included the following: (a) Sleep Diary; (b) 
Actigraphy; (c) Behavior Diary; and (d) the Children’s Sleep Habit Questionnaire 
(CSHQ). All measures were collected during baseline (4 to 14 days), end of treatment (11 
to 14 days), and at one month post-treatment (4 to 7 days). A Sleep Diary is a 
standardized parent-completed measure in the field of behavioral interventions and sleep 
medicine with a reasonable validity and high internal consistency (Corkum, Tannock, 
Moldofsky, Hogg-Johnson, & Humphries, 2001; Mindell & Durand, 1993).  
A traditional sleep diary, based on considerations from the literature (Patzold, 
Richdale, & Tonge, 1998; Weiskop, Matthews, & Richdale, 2001), was developed for 
this study. One parent per family recorded nightly information regarding their child’s 
sleep in the sleep diary throughout the duration of the study (see Appendix A). Outcomes 
recorded in the diary specific to sleep included (a) frequency and duration of night 
awakenings after sleep onset (FNA; WASO); (b) sleep onset latency (SOL); (c) total 
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sleep time (TST); (d) time in bed (TIB); and (e) independent versus dependent sleep 
initiation (ISO; DSO). Sleep efficiency (SE) outcomes were extrapolated from the sleep 
diary data [(TST/TIB) x 100] and expressed as a percentage. 
A slightly modified sleep-related behavior diary (Allen, Kuhn, DeHaai, & 
Wallace, 2013; Burke, Kuhn, & Peterson, 2004) was added to this study. The same parent 
recorded nightly information regarding their child’s sleep-related behaviors in the 
behavior diary throughout the duration of the study (see Appendix B). Diary outcomes 
specific to sleep-related behavior included (a) frequency and duration of undesired co-
sleeping (UC-S) with a parent or a sibling; (b) frequency and duration of bedtime 
resistance (BR; DBR); (c) frequency of sleeping in a non-designated area; and (d) the 
location of non-designated sleep (refer to Table 2 for a list of all dependent variables on 
the sleep and sleep related behavior diaries). Bedtime resistance (BR) frequencies were 
the sum total of the number of disruptive behaviors that occurred during the bedtime 
routine once the child was placed in bed and the number of times the child got out of the 
bedroom after being put in bed for the night. Disruptive Behavior Composite (DBC) 
mean frequency was determined by dividing the sum total of BR per data collection 
phase by the number of days during that period. Duration of bedtime resistance (DBR) 
outcomes were obtained by calculating the duration of disruptive behaviors during 
bedtime routine and once the child was placed in bed with the duration of time the child 
was out of the bedroom after being put in bed for the night.  
Treatment integrity is a measure of the extent to which treatment procedures are 
implemented as intended (Vollmer & Sloman, 2008). An integrity-monitoring sheet on 
the BFRC protocol (see Appendix C) was created for this study based on clinical 
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considerations and the literature (Burke, Kuhn, & Peterson, 2004; Durand & Mindell, 
199b; Vollmer & Sloman, 2008). Telephone calls were made to the designated parent 
responsible for data collection at least three times a week during the treatment phase 
(Burke, Kuhn, & Peterson, 2004; Durand & Mindell, 1999b). On randomly selected 
nights, parents answered a series of questions related to components of the BFRC 
procedure they implemented. Parent responses were recorded on the integrity-monitoring 
sheet, and a random sample of data collected, ranging from 43% to 71% of participant 
treatment data, was scored for fidelity. Treatment integrity outcomes were calculated by 
dividing the sum of correct parent responses by the total number of possible correct 
responses and multiplying the result by 100 (Vollmer & Sloman, 2008). The bedtime 
fading components were implemented with 96% integrity for Holly, 97% integrity for 
Bill, and 100% integrity for Keith. The response cost components were implemented with 
100% integrity for all three participants. 
To assess the reliability of data collection, periodic telephone checks were used to 
compare the level of agreement between parent-reported data and actual recorded data for 
the previous one to three nights during the treatment phase (Burke, Kuhn, & Peterson, 
2004; Durand & Mindell, 1999b). The researcher recorded parent verbal reports during 
each telephone check using a blank sleep diary and sleep-related behavior diary (see 
Appendix A and B). Random samplings of these telephone checks (i.e., 43% of data for 
Keith, 50% for Bill, 71% for Holly) were later matched and compared with the data 
forms returned by parents.  Data points were considered reliable if the difference between 
the reported and recorded durations varied by no more than 15 minutes and observed 
frequencies varied by no more than one point between data sets (Burke, Kuhn, Peterson, 
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2004). Reliability was calculated by dividing the sum of agreements by the sum total of 
agreements plus disagreements and multiplying the result by 100  [(∑ of agreements / [∑ 
of agreements + ∑ of disagreements]) x 100]. The result was expressed as a percentage 
(Durand & Mindell, 1999b). Level of agreement between the telephone checks and 
parent-recorded sleep diaries was 95% for Holly, and 97% for Bill and Keith each.  The 
level of agreement between parent-recorded sleep-related behaviors was 94% for Holly, 
98% for Keith, and 100% for Bill. 
Actigraphy is an objective measure of motor activity, which, in turn, provides 
reliable estimates of sleep-wake patterns in children (Meltzer, Montgomery-Downs, 
Insana, & Walsh, 2012). Actigraphy is considered a relatively unobtrusive method for 
recording sleep patterns in children. Children with autism and/or sensory issues may not 
tolerate wrist placement of the actigraph device; therefore, ankle placement is 
recommended (Ancoli-Israel, et al. 2015). The MicroMini Motionlogger actigraph 
(Ambulatory Monitoring, Inc.), a small sensor about the size of a wristwatch, was 
secured with a hospital band to each child’s ankle to continuously record movement. 
Parents were asked to have their child constantly wear the small actigraph on the same 
ankle, except during bathing or swimming. Zero Crossing Mode (ZCM) was used to 
count frequencies of signal-based movement for each epoch (e.g., 30 seconds or one 
minute). Activity data collected were downloaded from the sensor using Act Millennium 
(version 3.68.0.1) software. Data were scored using Action W (version 2) software and 
the Sadeh scoring algorithm (Sadeh, Sharkey, & Carskadon, 1994) to make inferences 
about the child’s sleep-wake cycles. Primary outcome variables included SOL, TST, SE, 
WASO, and TIB. 
BEDTIME FADING WITH RESPONSE COST  30    30  
 
 
The Children’s Sleep Habits Questionnaire (CSHQ) (Owens, Spirito, & 
McGuinn, 2000) is a widely used multidimensional measure to determine the frequency 
and topography of sleep behaviors for school-aged children between 4-10 years. The 
parent-completed questionnaire yields reliable psychometric properties with typically and 
non-typically developing children (Lewandowski, Toliver-Sokol, & Palermo, 2011). 
CSHQ abbreviated version (CSHQ-A) is composed of 33 items regarding bedtime, sleep 
behaviors, waking during the night, and morning waking/daytime sleepiness (Owens, 
Spirito, & McGuinn, 2000). Parents retrospectively reported their child’s sleep for the 
past week using a Likert scale indicating if the problem occurred “usually” (five to sever 
nights per week), “sometimes” (two to four nights per week), or “rarely” (zero to one 
night per week). Parents also indicated if the sleep habit was a problem by circling “Yes”, 
“No”, or “Not applicable (N/A)”. Items were scored within 8 subscales (i.e., bedtime 
resistance, sleep onset delay, sleep duration, sleep anxiety, night awakenings, 
parasomnias, sleep disordered breathing, and daytime sleepiness). Total sum of each 
subscale yielded a total sleep disturbance score (range of 33 to 87), with a proposed cut-
off score of 41; higher scores indicate more sleep problems.  
Three measures were selected to capture the impact of and satisfaction with 
treatment for the family. The Goal Achievement Scale (GAS) quantifies progress on 
parent-identified treatment goals and assesses the clinical significance of change in sleep 
behavior (Hudson, Wilken, Jauering, & Raddler, 1995). For each identified treatment 
goal (i.e., sleep related behavior), 0% success (i.e., no improvement) was the set baseline 
rate. Before treatment, parents (with guidance from a member of the research team on 
developmentally appropriate behaviors) decided what would constitute 100% (total) 
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success for each goal. Success was dependent on the parents’ level of desired 
improvement, not on the total elimination of a problem behavior. Change in each goal 
was expressed as a percentage of success over baseline. For example, parents reported 
wanting to reduce the frequency of co-sleeping. Parents’ goals represented a personally 
acceptable level of co-sleeping (e.g., 2 out of 7 nights per week). Baseline rate of 
undesired co-sleeping (e.g., occurring 7 out of 7 nights per week) was set at 0% success, 
whereas the goal for 100% total success depended on parents’ preference (e.g., 
eliminating all but 2 of the 7 nights of co-sleeping per week).  
The Parent’s Customer Satisfaction Questionnaire (PCSQ) is a 42-item 
questionnaire to evaluate treatment satisfaction (McMahon & Forehand, 2003). For the 
purposes of this study, only 16 questions specific to treatment satisfaction were used; 11 
items corresponded to a Likert scale (e.g., 1 (considerably worse) to 7 (greatly 
improved)). Wording of each response option varied according to the question being 
asked (e.g., 1 = Very dissatisfied to 7 = Very satisfied; 1 = Strongly not recommended to 7 
= Strongly recommended; 1 = Very inappropriate to 7 = Very appropriate; 1 = Very 
pessimistic to 7 = Very optimistic). Parents evaluated the overall treatment protocol by 
rating the degree to which they endorsed each statement and answered 5 open-ended 
questions related to usefulness of the treatment. 
The Kansas Marital Satisfaction Scale (KMSS) is a brief 3-item measure designed 
to rapidly assess relationship satisfaction of married individuals or couples (Crane, 
Middleton, & Bean, 2000). The KMSS is described as a “reliable and economical” tool 
for measuring satisfaction with marriage, partners, and marital relationships. Parents 
separately completed the KMSS by reading each item and marking on the corresponding 
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scale of 1 (extremely dissatisfied) to 7 (extremely satisfied) the degree to which they 
agreed with each statement (Schumm, Nichols, Schectman, & Grigsby, 1983). A possible 
score for each item ranges from 1 to 7; a cut-off score of 17 distinguishes between 
distressed and non-distressed couples, with a total individual score of 16 or lower 
indicating marital distress (Crane, Middleton, & Bean, 2000).  
Procedure 
Initial Interview  
Parents of prospective participants completed a 15-minute telephone screening 
followed by a face-to-face interview to determine eligibility. During this interview, 
parents and children met with a member of the investigated team to complete the CARS-
2, baseline CSHQ-A, and a demographic questionnaire. A classification of either Severe 
or Mild-to-Moderate ASD resulted in the administration of the ADOS-2. Depending on 
parents’ availability, the ADOS-2 was completed either during the initial session or 
scheduled for another time that week. Parents were invited to participate in the study 
once a diagnosis of autism was confirmed and all other eligibility criteria were met. The 
consent form was reviewed and parents completed the KMSS. 
Pre-Baseline  
Prior to baseline data collection, parents meet with a member of the investigative 
team for a second session to identify their specific treatment goals. Parents were 
instructed in the recording of data in the sleep and behavior diaries. They received 
feedback from a trained clinician as they completed sample diaries for two vignettes 
describing detailed sleep patterns and sleep-related behaviors (see Appendix D). Once 
parent dyads correctly completed the sample diaries, they were provided blank diaries 
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and an actigraph to begin collection of data on their child’s sleep patterns and sleep-
related behaviors (Christodulu & Durand, 2004; Reed et al, 2009).   
Baseline  
Parents met with a member of the investigative team once a week during the 
baseline phase of the study for approximately 30 minutes to review the sleep and 
behavior diaries and exchange actigraphs. Once baseline data were determined stable, or 
14 consecutive days of data was collected, the treatment phase was introduced, and 
parents were taught to implement the BFRC protocol. Parents were instructed in the 
implementation of a modified BFRC protocol (i.e., bedtime procedures, response cost, 
and bedtime fading) and received an outline of procedures (see Appendix E).  
Bedtime fading instructions included: 
(i) Adjust bedtime for the following night according to child’s previous time of 
sleep onset by 15 minutes. For example, if child’s initial bedtime was 10:30 
p.m., and he/she fell asleep within 15 minutes of being placed in bed, fade the 
bedtime to 10:15 p.m.; and 
(ii) If child did not fall asleep within 15 minutes of the initial bedtime, push back 
the bedtime to 10:45 p.m.  
Bedtime procedures included: 
(i) Follow regular bedtime routine and place child in his/her bed at the initial 
adjusted bedtime; 
(ii) After 15 minutes, check to see if child is awake by standing within one foot of 
the bed and whispering his/her name. If there are no observable motor or 
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verbal responses (i.e., opening eyes, talking, etc.) it is safe to assume child is 
asleep; and 
(iii) If determined that child is awake (i.e., he/she responded to whisper), 
implement response cost.  
Response cost procedures included: 
(i) Remove child from the bed and bedroom and allow him/her to partake in 
activities not related to sleep for 30 minutes, such as playing with toys or 
watching TV; and 
(ii) At the end of 30 minutes, return child to his/her bed; 
(iii) Repeat the procedure if your child does not fall asleep within 15 minutes of 
being returned to bed; and 
(iv) Address nighttime awakenings by returning child to his/her bed with minimal 
parental attention and interaction.  
Parents received feedback from a trained clinician as they verbally described how 
to implement BFRC with their child. Once parent dyads correctly reported how to 
implement each component of BFRC, they were provided blank diaries and an actigraph 
to begin treatment phase data collection. Finally, each parent completed the KMSS 
independently, once weekly for the duration of the study. 
Treatment  
A member of the investigative team assisted parents in determining parent-
preferred bedtime goals. A consistent wake time and naptime (if applicable) were derived 
using developmental norms (Iglowstein, Jenni, Molinari, & Largo, 2003) and parent sleep 
goals. Baseline data were used to determine the initial bedtime by calculating the average 
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sleep onset time and adding 30 minutes. Parents were asked to enforce a consistent wake 
time every morning regardless of their child’s sleep behaviors the night before. Parents 
were also asked to eliminate access to non-established daytime sleep, such as naps, unless 
appropriate for the age and developmental needs of their child. Parents were required to 
regulate the timing and duration for any established naps, regardless of the amount or 
quality of sleep the child had the night before, and to not permit access to sleep outside of 
the designated times. If the child eloped from the bedroom, parents were asked to return 
him or her to bed and ignore all disruptive behaviors as long as they were not harmful to 
the child or others.   
Parents were taught a modified BFRC protocol and received an outline of the 
following procedures: (a) Bedtime protocol: (i) Follow the regular bedtime routine and 
place child in his/her bed at the initial adjusted bedtime. (ii) After 15 minutes, check to 
see if child is awake by standing within one foot of the bed and whispering his/her name. 
If there are no observable motor or verbal responses (i.e., opening eyes, talking, etc.), it is 
safe to assume the child is asleep. (iii) If the child is awake (i.e., he/she responded to your 
whisper), implement response cost. (b) Response cost: (i) Remove child from the bed and 
bedroom and allow him/her to partake in activities not related to sleep for 30 minutes, 
such as playing with toys or watching TV. (ii) At the end of 30 minutes, return child to 
his/her bed. (c) Repeat the procedure if child does not fall asleep within 15 minutes of 
being returned to bed. (d) Address nighttime awakenings by returning child to his/her bed 
with minimal parental attention and interaction. (e) Bedtime fading: (i) Adjust the 
bedtime for the following night according to child’s previous time of sleep onset by 15 
minutes. For example, if child’s initial bedtime was 10:30 p.m., and he/she fell asleep 
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within 15 minutes of being placed in bed, fade the bedtime earlier by 15 minutes to 10:15 
p.m.. If the child did not fall asleep within 15 minutes of the initial bedtime, push the 
bedtime later by 15 minutes to 10:45 p.m.  
After being trained to implement the BFRC protocol, parents continued to meet 
with a member of the investigative team once a week for approximately 30 minutes to 
review sleep and behavior diaries and exchange actigraphs. During the treatment phase, a 
researcher contacted the designated parent responsible for data collection by telephone 
approximately every other day to check on “data collection efforts” (Durand & Mindell, 
1999). Parents answered a series of questions related to the BFRC procedures and data 
collected. Information provided was recorded in a modified diary and compared with 
parent completed sleep and behavior diaries at the end of the study. Parents were asked to 
complete the CSHQ-A at the end of the treatment phase.  
Follow-up 
 Approximately four weeks after the end of treatment, parents met with a member 
of the investigative team for approximately 30 minutes to receive data sheets and an 
actigraph. Parents collected sleep and behavior data for a minimum of 4 and maximum of 
7 consecutive days. At the end of the follow-up data collection phase, parents attended a 
closing session to complete the CSHQ-A and PCSQ and return data and the actigraph. 
Parents attended between five and eight sessions to complete the study, depending on 
outcomes (see Table 3). For example, if a stable trend in the baseline and treatment data 
was observed, then sessions two, three, four, and five were consolidated into two 
sessions. 
Research Design 
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A non-concurrent multiple baseline design across participants was used (Harvey, 
May, & Kennedy, 2004; Watson & Workman, 1981). Baseline lengths were staggered 
across participants and information was collected until data stability and trend were 
observed or for a maximum of 14 days if stability was not observed, followed by a 
maximum of 14 days for the treatment phase. It was expected that changes may occur in 
each participant’s sleep behavior under the treatment condition, while participant’s sleep 
behavior during baseline may remain unchanged. Follow-up measures were collected one 
month following the conclusion of treatment, for a maximum duration of one week. 
Visual inspection of baseline data was utilized to assess stability and trends in the data 
and determine the introduction of the treatment phase for each individual participant 
(Harvey, May, & Kennedy, 2004; Watson & Workman, 1981). For example, once the 
frequency of Bill’s undesired co-sleeping was stable and the trend was not decreasing 
(after 6 days), the treatment phase was initiated. Similarly, when the frequency of Keith’s 
undesired co-sleeping was not stable or the trend was decreasing, treatment was delayed 
until baseline data demonstrated a stable trend in the desired direction (or for a total of 14 
days). This time-lagged approach demonstrates experimental control through the 
sequential introduction of treatment once stable baseline levels in the dependent variables 
were observed (Harvey, May, & Kennedy, 2004).  
Data analysis  
Means and standard deviations were calculated for WASO, SOL, TST, and SE 
from data recorded by actigraphy and in sleep diaries (Moon, Corkum, & Smith, 2010). 
Mean frequencies and standard deviations for FNA, DSO, and non-designated sleep were 
calculated from data recorded in the sleep and behavior diary. Means and standard 
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deviations for undesired co-sleeping were also calculated using data recorded in behavior 
and sleep diaries (Weiskop, Matthews, & Richdale, 2001). Raw scores on the CSHQ-A 
subscales of bedtime resistance, sleep onset delay, sleep duration, sleep anxiety, night 
awakenings, parasomnias, sleep disordered breathing, and daytime sleepiness were 
reported (see table; Moon, Corkum, & Smith, 2010). Daily means for the frequency and 
duration of disruptive behaviors were calculated using data from the sleep and behavior 
diaries (Weiskop, Richdale, & Matthews, 2005). Level of success of parents’ treatment 
sleep goals was calculated using the GAS at the end of baseline, intervention, and follow-
up conditions and expressed as % (Weiskop, Matthews, & Richdale, 2001; Weiskop, 
Richdale, & Matthews, 2005). Mean level of satisfaction (%) was also calculated from 
KMSS raw scores for each parent during all three phases.  
Results 
 Data from each child were analyzed individually because a non-concurrent 
multiple baseline design across participants was used in this study. Changes in trends and 
patterns for the primary dependent variables are provided below. Each of the three 
parents dyads generated sleep-related goals for their own child and worked with a 
member of the investigative team to refine and determine the levels of success for each 
goal (see Table 4).  
Undesired co-sleeping 
Undesired co-sleeping was the only sleep problem consistently reported by the 
parents of all three participants. Parents generated a goal using the GAS to reduce 
undesired co-sleeping in the parent’s bed (see GAS section for details). Frequency and 
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duration of undesired co-sleeping with parents reduced after the onset of BFRC for all 
three children as measured by the sleep-related behavior diaries (see Figures 1 and 2). For 
Holly, undesired co-sleeping occurred once per night during baseline, averaging 653 
minutes per night. This decreased to 0 minutes during treatment and was maintained at 
that level at follow-up. Bill’s frequency of undesired co-sleeping was once per night 
throughout baseline, with a mean duration of 230 minutes per night, which also decreased 
to 0 minutes during treatment and was maintained at that level at follow-up. It should be 
noted that on the third night of treatment, Bill’s parent chose to co-sleep with him in the 
child’s bed for 90 minutes after an instance of bedwetting. This occasion did not meet the 
definition of undesired co-sleeping; therefore, the frequency and duration were not 
included in the final data set. Alternatively, had this one-time occurrence been included, 
undesired co-sleeping decreased from baseline to 0.1 occurrences and an average of 6 
minutes per night at the end of treatment. Keith demonstrated a dramatic decrease from 
the mean frequency of 2 occurrences per night (mean duration of 57 minutes per 
occurrence) during baseline to 0.1 occurrences and an average of 1 minute per night 
during treatment. One episode of undesired co-sleeping occurred on the last night of the 
treatment phase in the parents’ bed for 15 minutes. Undesired co-sleeping for Keith 
slightly increased to 0.3 occurrences, with a mean duration of 9 minutes per night, 
throughout follow-up. These instances occurred on separate days in the parent’s bed, 
lasting less than 45 and 15 minutes each.  
Non-designated sleep 
Frequency and location of sleeping in a non-designated area were reported for Bill 
and Keith, whereas Holly maintained zero occurrences during all three phases of the 
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study. Both Bill and Keith showed reduction in the frequency of sleeping in a non-
designated area. For Bill, mean frequencies of sleep in a non-designated area (location 
not reported) decreased from 0.16 occurrences during baseline to zero occurrences 
throughout treatment. For Keith, mean frequencies of sleep in a non-designated area 
decreased by half from baseline (0.13) (located in the car and on the couch) to treatment 
(0.06) (located in the car). This single episode of sleeping in a non-designated area 
occurred during a change in routine. Keith’s parents reported they had traveled by car out 
of town for the day, and the return trip coincided with Keith’s bedtime, at which time he 
fell asleep and remained asleep for the duration of the car ride (2.5 hours). Follow-up 
data demonstrated a total elimination of sleeping in a non-designated area for Bill and 
Keith.  
Bedtime resistance  
Bedtime resistance (BR) was a reported concern for Bill’s parents only, although 
all three children engaged in disruptive behaviors during the bedtime routine and after 
being placed in bed, as recorded in the sleep-related behavior diaries (see Figure 3). For 
Holly, mean duration of BR per night decreased from 15 minutes during baseline to 0.4 
minutes at the end of treatment and further decreased to 0.3 minutes during follow-up. 
Night-by-night inspection of Holly’s sleep-related behavior diary indicated a one-time 
change in her bedtime routine (i.e., attending a party for 30 minutes past bedtime), which 
may have contributed to the duration of BR during follow-up. Both Keith and Bill 
experienced extinction bursts (increase in mean duration of BR) during the treatment 
phase, with a sharp decrease beyond baseline levels during follow-up. Bill’s mean 
duration of BR per night greatly increased from baseline (12.4 minutes per night) to 
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treatment (55 minutes per night) and then significantly decreased throughout follow-up (4 
minutes per night). For Keith, BR mean duration per night increased from baseline (1.3 
minutes per night) to treatment (6.3 minutes per night), and decreased to near 0 minutes 
during follow-up (0.1 minutes per night). Overall, Keith’s BR duration increased by only 
an average of 5 minutes during treatment and reduced by 6.2 minutes at follow-up.  
Parents in this study reported no occurrences of aggressive behavior when 
returning the child to their own bed following elopement. Night-by-night sleep-related 
behavior diary for Bill indicated a spike in BR duration by 150 minutes the same day he 
experienced a significant deviation in routine (i.e., attended only ½ day of school and no 
swim class), which was preceded and succeeded by nights with BR rates of zero. Bill’s 
parents noted this change in schedule might have greatly contributed to his resistance to 
bedtime. Bill’s CSHQ-A bedtime resistance subscale scores decreased from baseline (9) 
to treatment (6) and were maintained during follow-up (6). Likewise, Keith’s CSHQ-A 
bedtime resistance subscale scores decreased from baseline (12) to treatment (7) and were 
maintained during follow-up (6). Holly’s CSHQ-A bedtime resistance baseline subscale 
score of 14 decreased to 6 during follow-up. 
Disruptive behavior composite 
Mean scores of Disruptive Behavior Composite (DBC) were extrapolated from 
the sleep-related behavior diaries and patterns similarly to the mean durations and 
frequencies of BR for all three children (see Figure 4). Holly’s DBC mean scores 
decreased slightly from the baseline (1.3 per night) to the end of treatment (1.2 per night) 
and displayed a downward trend. Her DBC further decreased during follow-up (0.5 per 
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night). Night-by-night inspection indicated that disruptive behaviors during her bedtime 
routine or after she was placed in her bed for the night were eliminated, and only the 
number of times she escaped from her bedroom after being put in bed for the night 
contributed to her DBC mean scores. Holly’s nightly DBC scores varied throughout 
treatment with a subtle downward trend that remained below baseline at the end of 
follow-up. A change in Holly’s routine may have contributed to one of two instance of 
BR during follow-up, thus increasing her DBC. Bill’s DBC increased slightly from 
baseline (5.3 per night) to treatment (5.7 per night).  
Similarly to Holly’s, Bill’s night-by-night data indicated that disruptive behaviors 
during his bedtime routine decreased to almost none. Furthermore, Bill’s disruptive 
behaviors occurring after he was placed in his bed for the night decreased, while the 
number of times he came out of his bedroom after being placed in bed for the night 
increased during treatment. Visual analysis of the plotted data showed an unexpected 
uptick in the frequency of BR on the same day Bill experienced a significant deviation 
from his daily routine. Such deviation may have negatively impacted his DBC. His DBC 
decreased throughout follow-up to 2 per night. As for Keith, his DBC doubled from 
baseline (1.1 per night) at the end of treatment (2.2 per night) and decreased to near 0 
minutes during follow-up (0.1 per night) with no clinically relevant differences across 
topography.  
Night awakenings 
Frequent night awakenings (FNA) were a parent-reported sleep problem for Bill 
and Keith. Both children showed some decrease in the number of night awakenings 
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during the implementation of BFRC as measured by sleep diaries (see Figure 5). Bill’s 
FNA slightly decreased from 1.2 occurrences per night at baseline to an average of 1 per 
night throughout treatment, whereas Keith’s FNA per night decreased from 0.6 per night 
at baseline to 0.3 per night during treatment. Night-by-night sleep diary data for Bill 
indicated a progressive decrease in FNA during treatment with four consecutive nights of 
zero night awakenings nearing the end of treatment with an increase in FNA the 
following night. Bill used the bathroom independently once that night, which accounts 
for one FNA. Bill’s parents indicated a deviation from his typical daytime routine 
resulting in a lack of exercise, which might have had a negative impact on his sleep and 
contributed to the unexpected increase of FNA. Additionally, at least one night 
awakening on each of the first, third, and fourth nights of the treatment phase were the 
result of bedwetting and required parental assistance in changing bedding and pajamas. 
These instances were not recorded as FNAs. Follow-up data demonstrated a total 
elimination of FNA for Bill and Keith. 
Holly experienced an increase and fluctuation in the frequency of night 
awakenings from baseline (0 per night) to a mean frequency of 0.7 per night during 
treatment, which returned to near baseline levels during follow-up (0.5 per night). Prior to 
BFRC, Holly slept through the night in her parents’ bed with at least one parent in the 
room at all times. This standard might have been greatly reducing the likelihood of FNA. 
Therefore, the adjustment to sleeping alone in her own bed may have produced FNA 
during treatment. Visual analysis of the data showed FNA decreased to zero the last night 
of treatment, maintained the first three nights of follow-up, and increased by 2 instances 
the final night of follow-up due to a change in routine (i.e., party attendance and delayed 
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bedtime). Bill’s CSHQ-A night wakings subscale scores decreased from baseline (7) to 
treatment (6), and further decreased during follow-up (4), whereas Holly’s CSHQ-A 
bedtime resistance subscale score remained stable from baseline (5) throughout follow-
up. Keith’s CSHQ-A night wakings subscale scores decreased from baseline (7) to 
treatment (4) and then slightly increased during follow-up (5).  
Dependent sleep onset 
Dependent sleep onset (DSO) was a parent-reported problem for Holly and Keith 
as both children required a parent in the room to fall asleep. DSO, as measured by the 
sleep diaries, was eliminated for all three children (see Figure 6). Holly’s DSO occurred 
steadily once per night during baseline, whereas Keith’s baseline DSO varied between 1 
and 3 times per night with a mean frequency of 1.7 per night. Bill’s baseline DSO 
generally occurred once a night with a mean frequency of 1.2 occurrences per night. Each 
child’s DSO decreased to zero after the onset of BFRC and remained at the 0-per-night 
level at follow-up.  
Sleep onset latency  
Night-by-night inspection of mean sleep onset latency (SOL), as measured by 
sleep diaries, revealed an overall reduction in SOL at during follow-up for Bill and Keith, 
whereas Holly’s mean SOL increased above baseline (see Table 5). Bill’s baseline mean 
SOL (57.5 minutes) decreased by over 50% by end of treatment (25.7 minutes), and 
again at follow-up (11.3 minutes). This clinically meaningful improvement highlights the 
effectiveness of BFRC in the reduction of SOL for a child with ASD that experienced 
significant sleep onset delays. Visual analysis of Bill’s night-by-night sleep diary data 
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showed an increase in SOL the same day he experienced a change in routine, suggesting 
a more consistent schedule may have resulted in greater improvement of SOL. Keith’s 
mean SOL baseline (9.6 minutes) –  already an acceptable level of latency – greatly 
increased during treatment (33.2 minutes). This abrupt increase in SOL occurred the first 
night of treatment; SOL progressively decreased and remained at a lower level during 
follow-up (4.3 minutes). 
Mean SOL recorded by actigraphy decreased from baseline to the end of 
treatment for Holly and Bill (see Table 5). Actigraphy treatment phase data for Keith 
were lost due to a software malfunction. Actigraphy data on Holly’s mean SOL indicated 
a decrease of 29.7 minutes from baseline (43.5 minutes) to treatment (13.8 minutes) with 
a return toward baseline levels (32 minutes) at the end of follow-up. Bill’s mean SOL 
decreased by 50 minutes from baseline (74 minutes) to treatment (24 minutes) and 
increased by 7.3 minutes at follow-up (31 minutes). Keith’s remaining actigraphy data 
indicated his mean SOL decreased from baseline (13 minutes) to follow-up (5.6 minutes) 
by 7.4 minutes. Bill’s CSHQ-A sleep onset delay subscale scores decreased from baseline 
(3 minutes) to treatment (1 minute) and were maintained during follow-up (1 minute). 
Holly and Keith’s CSHQ-A sleep onset delay subscale scores of 1 were maintained 
throughout the study. 
Waking after sleep onset 
Mean values of night awakenings after sleep onset (WASO) in minutes, as 
measured by sleep diaries, revealed a progressive reduction in night-awakenings after 
sleep onset for Keith, whereas Holly’s and Bill’s mean WASO increased from baseline 
levels at the end of treatment (see Table 5). Keith’s WASO in minutes decreased from 16 
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minutes at baseline to 6.4 minutes during treatment and to zero during follow-up. Holly’s 
WASO increased from 0 minutes at baseline to 29 minutes at the end of treatment, 
followed by a decrease to 11.3 minutes during follow-up. Visual analysis of the data 
showed WASO maintained duration of 0 minutes on the first three out of four nights of 
follow-up and increased by 45 minutes on the final night. This increase corresponds with 
the uptick of FNA on the same night and may also be contributed to a change in Holly’s 
bedtime. Bill’s WASO increased by 6 minutes from baseline (35 minutes) to treatment 
(41 minutes) and decreased to 0 minutes at follow-up. Akin to his FNA sleep diary data, 
Bill’s night-by-night data showed a progressive decrease in mean WASO during 
treatment. Specifically, Bill experienced four consecutive nights of 0 minutes awake after 
sleep onset toward the end of treatment. The following night, WASO increased by 180 
minutes (3 hours), which may have resulted from the unexpected change in his daytime 
routine and activity level. 
WASO recorded by actigraphy decreased from baseline to the end of treatment 
for Holly and Bill (see Table 5). As previously reported, actigraphy treatment phase data 
for Keith were lost due to a software malfunction. Holly’s mean WASO decreased by 
101 minutes from baseline (192 minutes; 3.2 hours) to treatment (91.3 minutes; 1.5 
hours), with a return toward baseline levels (132.5 minutes; 2.2 hours) at the end of 
follow-up. Bill’s mean WASO decreased by 55 minutes from baseline (105 minutes; 1.8 
hours) to treatment (50 minutes), and the decrease was maintained at follow-up. Keith’s 
remaining actigraphy data indicated his mean WASO increased slightly from baseline (51 
minutes) to follow-up (57 minutes).  
Time in bed 
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Time in bed (TIB) means measured in minutes by sleep diaries revealed an 
overall reduction in time spent in bed from baseline through follow-up for all three 
children. This calculation included the total amount of time the child was physically in 
bed during a 24-hour period. Holly and Keith’s TIB progressively reduced throughout the 
study, whereas Bill’s TIB slightly increased during follow-up (see Table 5). Bill’s mean 
TIB decreased by 1 hour and 14 minutes from baseline (595 minutes; 9.9 hours) to 
treatment (521 minutes; 8.7 hours). His mean TIB slightly increased – by 27 minutes – 
from treatment to follow-up (548 minutes; 9.1 hours). Holly’s mean TIB baseline (671 
minutes; 11.2 hours) decreased by 45 minutes at the end of treatment (626 minutes; 10.4 
hours), followed by an additional decrease of 11 minutes during follow-up (615 minutes; 
10.3 hours). Keith’s mean TIB decreased from baseline (638 minutes; 10.6 hours) by 13 
minutes at the end of treatment (625 minutes; 10.4 hours), and another 12 minutes at the 
end of follow-up (613 minutes; 10.2 hours). Overall, TIB means reduced from baseline to 
follow-up by 56 minutes for Holly, 47 minutes for Bill, and 25 minutes for Keith. 
Correspondingly, TIB recorded by actigraphy decreased for all three children (see 
Table 5). Holly’s mean TIB decreased by approximately 1 hour from baseline (667 
minutes; 11.1 hours) to treatment (605 minutes; 10.1 hours) and increased by 37 minutes 
from treatment to the end of follow-up (642 minutes; 10.7 hours). Similarly, Bill’s mean 
TIB decreased by 1 hour and 41 minutes from baseline (609 minutes; 10.2 hours) to 
treatment (508 minutes; 8.5 hours) and increased by 41 minutes throughout follow-up 
(549 minutes; 9.2 hours). Holly experienced an overall reduction in TIB of 25 minutes 
(31 minutes less than recorded in sleep diaries), whereas Bill’s TIB reduced by 1 hour (13 
minutes more than recorded in sleep diaries). Much the same, Keith’s mean TIB 
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decreased from baseline (598 minutes; 10 hours) to follow-up (567 minutes; 9.5 hours) 
by 31 minutes (6 minutes more than recorded in sleep diaries).  
Total sleep time 
Total sleep time (TST) means measured by sleep diaries decreased from baseline 
to the end of treatment for all three children (see Table 5). TST was calculated by adding 
the durations of daytime and nighttime sleep within a 24-hour period. None of the parent 
dyads scheduled naptimes for their child; therefore a majority of sleep took place during 
the night. Holly’s baseline mean TST (653 minutes; 10.9 hours) decreased by the end of 
treatment (551 minutes; 9.2 hours) by 1 hour and 42 minutes and then increased by 27 
minutes during follow-up (578 minutes; 9.6 hours). Her average decrease in mean TST 
was 1 hour and 15 minutes. Bill’s baseline mean TST (503 minutes; 8.4 hours) decreased 
by 57 minutes by the end of treatment (446 minutes; 7.4 hours) and reverted above 
baseline levels by 30 minutes (533 minutes; 8.9 hours) during follow-up. 
Although none of the parents were interested in adding naps to their child’s sleep 
routine, Keith’s parents reported he had been allowed to nap during the day occasionally 
due to not sleeping either most or all of the night. This decreased the likelihood of him 
successfully sleeping through the night. Keith took two naps throughout the entire study, 
each on separate days during baseline. The first nap (15 minutes, 11:45 a.m.to 12:00 
p.m.) occurred after sleeping for only 8.25 hours the night before with a terminal wake 
time of 2:00 a.m. Two days later, the second nap (3.75 hours, 8:15 a.m.to 12:30 p.m.) 
occurred after sleeping only 4.5 hours the night before with a terminal wake time of 
11:00 p.m. Naps were eliminated for Keith at the onset of BFRC; this practice was 
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maintained through follow-up. Both naps included, Keith’s mean baseline TST (599 
minutes; 10 hours) decreased by 20 minutes by the end of treatment (579 minutes; 9.7 
hours). His TST also reverted above baseline levels by 10 minutes (609 minutes; 10.2 
hours) during follow-up. 
Mean TST recorded by actigraphy increased for Holly and Bill and decreased for 
Keith from baseline to follow-up (see Table 5). Holly’s mean TST actigraphy data 
increased by 1 hour and 32 minutes from baseline (399 minutes) to treatment (491) and 
decreased by 16 minutes by the end of follow-up (475). Her overall TST increased by 1 
hour and 16 minutes. Bill’s mean TST decreased by 13 minutes from baseline (415) to 
treatment (402) and increased by 1 hour and 2 minutes by the end of follow-up (464). His 
overall TST increased by 49 minutes. Keith’s mean TST decreased from baseline (525) to 
follow-up (502) by 23 minutes. Bill’s CSHQ-A sleep duration subscale scores did not 
change from baseline (5) to treatment (5) and decreased during follow-up (3), whereas 
Holly’s CSHQ-A sleep duration subscale scores did not change from baseline (3) through 
follow-up. Keith’s CSHQ-A sleep duration subscale scores decreased from baseline (6) to 
treatment (3) and did not change during follow-up (3).  
Sleep efficiency 
Sleep efficiency (SE) outcomes extrapolated from sleep diaries data indicate all 
three children overall maintained or improved the percentage of their sleep efficiency. 
Holly’s baseline SE of 97% decreased to 88% at the end of treatment and increased to 
94% during follow-up. Bill’s baseline SE increased slightly from 85% to 86% at the end 
of treatment, and further increased to 97% during follow-up. Keith’s baseline SE of 94% 
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decreased slightly to 92% at the end of treatment and increased to 99% throughout 
follow-up. Compared with these data, SE outcomes extrapolated from actigraphy data 
were lower for each child. For example, Holly’s baseline SE of 60% increased to 82% at 
the end of treatment, and decreased to 75% during follow-up. Bill’s baseline SE 
increased from 68% to 80% at the end of treatment, and further increased to 85% during 
follow-up. Keith’s baseline SE of 89% was maintained during follow-up. 
Children’s Sleep Habits Questionnaire, Abbreviated Version 
BFRC led to a significant reduction in the Children’s Sleep Habits Questionnaire, 
Abbreviated Version (CSHQ-A) total sleep disturbance scores for all three children. Total 
sleep disturbance scores drastically decreased from the clinical range during baseline to 
the non-clinical range by follow-up for two children, whereas the third child’s follow-up 
score was only 1 point above the proposed clinical cutoff score (41). Specifically, Bill’s 
baseline CSHQ-A total score of 48 decreased to 43 at the end of treatment, and further 
decreased to 36 during follow-up, with an overall decrease of 12 points. Keith’s total 
baseline score of 60 significantly decreased to 46 at the end of treatment, with an 
additional decrease to 42 during follow-up, with a decrease of 18 points, which represents 
the  the greatest improvement among the study participants. Likewise, Holly’s CSHQ-A 
total score at baseline (56) decreased by the end of follow-up (40), leaving her with the 
second best reduction in score of 16 points. 
As previously mentioned, Holly’s CSHQ-A subscale scores for sleep onset delay 
(1), sleep duration (3), and night wakings (5) remained unchanged from baseline 
throughout follow-up (EOT data not available), whereas bedtime resistance significantly 
decreased from 14 to the minimum score  of 6 (see Table 5). Similarly, Keith’s CSHQ-A 
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subscale score for sleep onset delay remained unchanged throughout the study at a 
baseline score of 1. In contrast to Holly’s score, Keith’s CSHQ-A subscale score for sleep 
duration decreased from baseline (6) by half at the end of treatment (3) and remained 
unchanged during follow-up. His CSHQ-A subscale score for night wakings also 
decreased from baseline (7) to treatment (4) but then slight increased at follow-up (5). 
Keith’s CSHQ subscale score for bedtime resistance decreased from baseline (12) to the 
end of treatment (7), with an additional decrease at follow-up (6).  
Bill’s CSHQ-A subscale score for sleep onset delay decreased from baseline (3) 
to the minimum score at the end of treatment (1) and did not change during follow-up. 
His CSHQ-A subscale score for bedtime resistance followed a similar pattern with a 
decrease from baseline (9) to the minimum score at the end of treatment (6), which did 
not change during follow-up. Bill’s CSHQ-A sleep duration subscale score maintained at 
baseline through end of treatment (5) and decreased to the minimum score (3) at the end 
of follow-up, whereas night wakings slightly decreased from baseline (7) to end of 
treatment (6), with a near minimal level decrease during follow-up (4). CSHQ-A sleep 
disordered breathing scores were reported within 1 point (range 3 to 4) of the minimal 
level (3) and determined non-clinically significant for all three children.  
Goal Achievement Scale 
Parents set sleep-related goals for their child and worked with a member of the 
investigative team to refine and determine the levels of success for each goal (see Table 
4). Keith had four goals, whereas Holly and Bill had two goals each. The only similar 
parent-set goal across all three children was to reduce undesired co-sleeping in the 
parent’s bed by having the child sleep alone in their own bed. The percentage of nights 
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during the treatment phase when each child slept in their own bed dramatically increased 
for all three children as measured by the sleep-related behavior diaries. Bill’s goal of 
sleep through the night in [his] own bed dramatically increased from 0% success (0 out 
of 6 nights) during baseline, to 100% success (14 out of 14 nights) at the end of treatment 
phase, which remained at 100% success (4 out of 4 nights) through follow-up.  
Similarly, Holly’s goal of sleep in [her] own bed (every night) increased from 0% 
success (0 out of 4 nights) during baseline to 100% success (11 out of 11 nights) at the 
end of the treatment phase and remained at 100% success during follow-up (4 out of 4 
nights). Keith’s goal of falling asleep on own (in [his] own bed) increased from 0% 
success (0 out of 14 nights) during baseline to 100% success (14 out of 14 nights) at the 
end of the treatment phase and remained at 100% success (7 out of 7 nights) during 
follow-up. Keith’s goal of sleeping through the night in [his] own bed (return to sleep 
during the night by himself) went from 0% success (0 out of 14 nights) during baseline to 
93% success (13 out of 14 nights) at the end of treatment. This goal’s success decreased 
to 75% (5 out of 7 nights) during follow-up due to briefly engaging in undesired co-
sleeping in the parent’s bed (mean of 9 minutes) on two separate nights. 
Bill’s and Keith’s parents had different goals related to the time their child went 
to sleep each night. Bill’s parents’ goal to go to sleep sooner (reduce SOL each night) 
was set at equal to or less than 15 minutes in order to achieve 100% success. He 
improved from 0% success (average of 57.5 minutes per night) during baseline to 75% 
success (average of 25.7 minutes per night) at the end of the treatment phase, which 
further increased to 100% success (average of 11.3 minutes per night) during follow-up. 
Keith’s parents’ goal of bedtime between 7:00 and 7:30 p.m. was set to 7 out of 7 nights 
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to achieve 100% success. This goal increased from 1% success (1 out of 14 nights) 
during baseline to 43% success (6 out of 14 nights) at the end of the treatment phase, and 
further increased to 86% success (6 out of 7 nights) during follow-up, thus indicating 
BFRC provided the structure necessary to achieve success.   
Holly’s and Keith’s parents had similar goals for the amount of sleep their child 
received each night. Members of the investigative team used sleep norms (Iglowstein, et 
al., 2003) to help parents set the goals. Norms for total sleep duration per 24-hour period 
range between 9.6 and 11 hours for children ages 8 and 9 years and between 10.5 and 
12.8 hours for children ages 4 to 5 years (Iglowstein, et al., 2003). Based on these norms, 
Holly’s goal to get required amount of sleep for [her] age (every night) decreased from 
50% success (2 out of 4 nights) during baseline to 18% success (2 out of 11 nights) at the 
end of the treatment phase, followed by a return to baseline level 50% (2 out of 4 nights) 
during follow-up. Keith’s goal to get enough sleep (developmentally appropriate amount 
per night) also decreased from baseline 36% success (5 out of 14 nights) to 21% success 
(3 out of 14 nights) at the end of the treatment phase and increased to 43% success (3 out 
of 7 nights) during follow-up.  
 In contrast to the recommendations published by Iglowstein and colleagues 
(Iglowstein, et al., 2003), the National Sleep Foundation recommendations on sleep 
duration per 24 hours are between 10 to 13 hours of sleep for children ages 3 to 5 years 
and between 9 and 11 hours for children ages 6 to 13 years (Hirshkowitz, et al., 2015). 
Even though these recommendations were not available at the beginning of our study, 
these norms were compared with Holly’s and Keith’s total sleep time (TST) values. The 
results of this comparison revealed a steady improvement in sleep duration goals for both 
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children. Holly’s baseline level of 50% success (2 out of 4 nights) increased to 64% 
success (7 out of 11 nights) at the end of the treatment phase, and further increased to 
100% success (4 out of 4 nights) during follow-up, whereas Keith’s baseline level of 57% 
success (8 out of 14 nights) remained stable through the end of the treatment phase and 
further increased to 71% success (5 out of 7 nights) during follow-up.  
Although sleep duration norms for children with ASD have yet to be established, 
Hodge and colleagues (Hodge, Carollo, Lewin, Hoffman, & Sweeney, 2014) found that 
children with ASD between ages 3 and 17 years experienced significantly less overall 
sleep (mean, 8 hours and 47 minutes; standard deviation, 93 minutes) compared with 
typically developing peers (mean, 9 hours and 22 minutes; standard deviation, 76 
minutes). Compared with these findings, Holly’s baseline level of 25% success (1 out of 
4 nights) increased to 82% success (9 out of 11 nights) at the end of the treatment phase, 
and further increased to 100% success (4 out of 4 nights) during follow-up, whereas 
Keith’s baseline level of 50% success (7 out of 14 nights) increased to 64% success (9 
out of 14 nights) at the end of the treatment phase and decreased to 29% success (2 out of 
7 nights) during follow-up (Hodge, Carollo, Lewin, Hoffman, & Sweeney, 2014). 
Kansas Marital Satisfaction Scale 
Parent-completed Kansas Marital Satisfaction Scale (KMSS) indicated a possible 
ceiling effect for two of the three parent dyads (see Table 6). Bill’s and Keith’s parents 
each reported being extremely satisfied (7) on all three KMSS probes (i.e., 1) How 
satisfied are you with your marriage?; 2) How satisfied are you with your husband/wife 
as a spouse?; and 3) How satisfied are you with your relationship with your 
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husband/wife?) at baseline, end of treatment, and follow-up. Therefore, Bill’s and Keith’s 
parents’ total individual KMSS scores were maintained at the ceiling level of 21 for each 
parent throughout the study, thus staying above the cut-off score of 17 for distressed 
couples. In contrast, Holly’s parents each endorsed being somewhat satisfied (5) with 
their marriage and very satisfied (6) with their husband or wife as a spouse and with their 
relationship with their husband or wife at baseline and end of treatment. Holly’s parents’ 
KMSS scores with regard to their marriage increased by 1 point each from somewhat 
satisfied to very satisfied (6), while the other scores remained unchanged through to 
follow-up. Total individual KMSS scores for Holly’s parents remained stable from 
baseline (17) through end of treatment and increased at follow-up (18), also staying 
above the cut-off score indicating marital distress. 
Parent’s Customer Satisfaction Questionnaire 
Parent’s Customer Satisfaction Questionnaire (PCSQ) mean-ratings indicate high 
levels of satisfaction with treatment implementation and outcomes across all three 
families. Holly’, Bill’s, and Keith’s parents endorsed that the major problems that 
originally prompted treatment and the problems treated during this study had greatly 
improved (mean rating of 7). All three parent dyads endorsed feeling very positive (mean 
rating of 7) about the treatment program, feeling very satisfied (mean rating of 7) about 
their child’s progress, and would strongly recommend (mean rating of 7) the treatment 
program to a friend or relative. Parental expectations for a satisfactory outcome of the 
treatment at the end of follow-up were optimistic (Keith) or very optimistic (Holly and 
Bill; mean rating of 6.66).  
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Each parent endorsed being very confident (mean rating of 7) in their ability to 
manage future in-home sleep problems based on what they learned during the study, 
whereas only Holly’s and Bill’s parents also endorsed being very confident (7) in their 
ability to manage current in-home sleep problems independently, resulting in an overall 
mean ratings of 5. This discrepancy in endorsements by Keith’s parents may due to the 
reverse selection of the response options for this particular question, suggesting a rating 
of 7 may have been intended as opposed to 1 (i.e., 1 = Very unconfident verses 7 = Very 
confident). Problems related to the children not treated during the study have either 
remained the same (Holly and Keith) or slightly improved (Bill; mean rating 4.33), 
whereas the degree to which the treatment program helped parents with other personal or 
family problems have either helped (Holly and Keith) or helped slightly (Bill; mean 
rating 5.66).  
In the open-ended questions, parents were invited to share their opinions on the 
best and worst components of the treatment program. The most helpful components 
included ‘sleeping in parents’ bed stopped completely’ for Bill; ‘getting her to sleep in 
her own bed’ for Holly; and ‘creating strict bedtime rules and sticking to it’ for Keith. 
Parents reported liking most the ‘results; treatment solved problems’ (Bill); ‘easy to 
follow/implement’ (Holly); and ‘having us have rules to establish a better bedtime 
routine’ (Keith). Bill and Keith’s parents liked least the ‘lack of sleep a few nights’ (Bill) 
and ‘first few days were difficult, but it got better. those days were tough! and data 
entry.’ (Keith). Holly’s parents indicated that there was nothing they liked least about the 
treatment program, whereas each parent dyad endorsed none of the treatment program 
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components as least helpful. Likewise, none of the parents reported any part of the 
treatment program as not helpful, nor did they offer recommendations for improvement.  
Discussion 
The results of this study add to the literature supporting BFRC as an effective 
treatment option for co-occurring sleep problems experienced by children with ASD. 
This study evaluated the effectiveness of BFRC as an in-home treatment with parents as 
change agents in decreasing parent-defined sleep disturbances, such as undesired co-
sleeping, night awakenings, difficulty falling asleep, and bedtime disturbances 
experienced by children with ASD. While this study centered on improving the sleep of 
children diagnosed with ASD by means of BFRC, innovative concepts of the study were 
to utilize parents to determine and implement treatment according to parent-derived sleep 
goals for their children.  
Previous BFRC research on sleep disturbances in children with ASD (DeLeon, 
Fisher, & Marhefka, 2004; Moon, Corkum, & Smith, 2010; Piazza, Fisher, & Sherer, 
1997) had not considered such novel aspects simultaneously. For example, two studies 
(DeLeon, Fisher, & Marhefka, 2004; Piazza, Fisher, & Sherer, 1997) were restricted to 
institutionalized settings with BFRC implemented by trained professionals, one study 
(Moon, Corkum, & Smith, 2010) involved training parents to implement BFRC in the 
home setting, and one study (Piazza, Fisher, & Sherer, 1997) used sleep norms in 
conjunction with parent goals to establish ideal sleep and wake times for their child. The 
current study extends both the science and practice of increasing parental agency while 
providing BFRC as a treatment option for children with ASD and co-occurring sleep 
disturbances. 
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The primary sleep problem across all three families – frequency and duration of 
undesired co-sleeping – improved for each child. Visual analysis showed improvement in 
baseline levels immediately following treatment onset. These improvements were 
maintained at one-month follow-up; thus, BFRC was effective in reducing (Keith) and 
eliminating (Holly and Bill) the frequency and duration of undesired co-sleeping. Neither 
frequency nor duration of undesired co-sleeping was negatively impacted by changes in 
routine for any of the children. Furthermore, parent goal for their child to sleep in their 
own bed were accomplished after the onset of treatment, and these outcomes were 
maintained across all children. Each of these outcomes offers compelling evidence for 
experimental control in a single-subject, non-concurrent multiple baseline design and 
meaningful implication for the effectiveness of BFRC as a parent-implemented home-
based intervention.  
This is the first study to demonstrate BFRC as an effective intervention for the 
elimination of undesired co-sleeping in children with ASD. Previously, Ashbaugh and 
Peck (1998) found that BFRC eliminated undesired co-sleeping with a typically 
developing child, whereas others (Piazza and Fisher, 1991b; Piazza, Fisher, and Moser, 
1991) noted reductions in undesired co-sleeping among children diagnosed with non-
ASD neurodevelopmental disorders. Previous BFRC studies in children with ASD 
primarily focused on changes in disruptive sleep-related behaviors, sleep latency, night 
awakenings, or sleep duration (DeLeon, Fisher, & Marhefka, 2004; Moon, Corkum, & 
Smith, 2010; Piazza, Fisher, & Sherer, 1997). The current study evaluated additional 
parent-determined sleep goals (i.e., reduce night awakenings and sleep onset, set bedtime, 
and obtain developmentally appropriate amount of sleep) as primary sleep problems and 
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sleep problems not identified as parent goals (i.e., BR, DBC, DSO, WASO, TIB, TST, 
SE) as secondary sleep problems. Nevertheless, these outcomes provide further evidence 
for a positive change following BFRC.  
Above and beyond the complete elimination of undesired co-sleeping, Holly also 
demonstrated meaningful improvements in sleeping in her own bed, falling asleep 
independently, and bedtime resistance. At the onset of treatment, Holly’s parents no 
longer had to remain next to her to get her to fall asleep or to sleep in her own bed 
throughout the night. Moreover, Holly no longer engaged in disruptive behaviors during 
her bedtime routine or after she was placed in her bed for the night. Time spent engaging 
in bedtime resistance dramatically improved after the onset of BFRC. These changes 
were clinically important to Holly’s parents because a substantial portion of their 
evenings were no longer occupied by conflict over sleep. Occasionally, she continued to 
come out of her bedroom after being put in bed for the night; however, frequencies of 
these minor disturbances remained below baseline levels at follow-up.  
Depending on the measurement method, Holly’s overall total sleep time 
decreased (sleep diary) or increased (actigraphy) from baseline to the end of follow-up. 
Unlike the other two children in this study, Holly did not experience difficulties with 
night awakenings prior to treatment. Nonetheless, both the number and the duration of 
night awakenings varied greatly during treatment and eventually returned to near baseline 
levels. This putative suppression of night awakenings during baseline may stem from her 
sleeping through the night in her parents’ bed with at least one parent in the room. 
Therefore, Holly’s night awakenings began after access to co-sleeping with a parent and 
dependent sleep onset were eliminated. It is worth noting that Holly experienced a change 
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in routine the last night of follow-up, which might have contributed to sleep problems 
experienced that night. 
In addition to the elimination of undesired co-sleeping, Bill also experienced 
noteworthy improvements in sleep latencies, bedtime resistance, and the number of night 
awakenings and started sleeping in his own bed and falling asleep independently. After 
the onset of BFRC, Bill no longer sought parental presence to initiate or reinitiate sleep 
and he was able to sleep through the night in his own bed independently. He also engaged 
in fewer disruptive behaviors during his bedtime routine that continued to improve 
throughout treatment and follow-up. By the end of follow-up, Bill was able to 
consistently achieve sleep onset within 15 minutes of bedtime. This outcome was 
clinically significant because prior to intervention Bill often took one to two hours a night 
to fall asleep, which may have inadvertently disrupted his parents’ sleep.  
According to both subjective and objective measures, Bill’s overall total sleep 
time increased from baseline to the end of follow-up. Night awakenings also 
progressively improved throughout treatment, however, Bill might have achieved greater 
improvement had it not been for a change in schedule and lack of daytime activity the 
second to last day of treatment. That same night, he experienced more frequent and 
longer lasting disruptive behaviors than he had the previous ten nights of treatment and 
spent the least amount of time sleeping out of any night during the entire study. Bill also 
took longer to fall asleep than he did the two nights before and had more night 
awakenings than he did the previous four nights. Nonetheless, his night awakenings were 
completely eliminated during follow-up. 
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Keith also demonstrated considerable improvements over and above a significant 
reduction in undesired co-sleeping, specifically in night awakenings, sticking to a set 
bedtime, sleeping in his own bed, falling asleep independently, and bedtime resistance. 
After the onset of BFRC, Keith experienced fewer night awakenings, which completely 
disappeared toward the end of treatment and remained absent throughout follow-up. As 
opposed to Holly’s data, Keith’s overall total sleep time from baseline to the end of 
follow-up increased, based on sleep diary data, or decreased, based on actigraphy data. 
Furthermore, Keith no longer required a parent in the room or in bed with him to fall 
asleep at bedtime or after night awakenings. Keith also engaged less often in bedtime 
refusal, following an expected extinction burst the first night of BFRC, when he was no 
longer permitted to sleep in his parents’ bed or with a parent in the room.  
Overall, the occurrence of Keith’s sleep-related disruptive behaviors gradually 
declined throughout treatment and remained rare at follow-up, with the exception of an 
unexplained uptick. A steady upward trend in the length of time Keith engaged in 
bedtime resistance began the third night of treatment, reaching its peak on the sixth night. 
The following night marked the descent to near baseline levels. Unfortunately, no 
information was provided that could reasonably account for this change in trend. As for 
sleep latencies, Keith’s data showed a sharp increase on the first night of treatment, 
followed by a progressive decline that was maintained during follow-up. This pattern 
likely indicates that for this child, the onset of treatment temporarily altered his sleep 
latency, and he was able to eventually adjust to his original set point of sleep onset within 
15 minutes of being placed in bed. Furthermore, this improvement was not clinically 
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meaningful as he was already achieving sleep within an acceptable range of latency 
(average within 10 minutes of being placed in bed) before treatment. 
In all BFRC studies with children on the autism spectrum, researchers determined 
treatment onset and primary sleep outcomes, with the exception of Piazza and colleagues 
(1997), who used sleep norms in conjunction with parent preferences to establish 
children’s sleep and wake times. In the current study, two children (Holly and Keith) had 
parent-determined goals for sleep duration based on sleep norms (Iglowstein, et al., 
2003). At the time of our study, the most current and complete sleep duration norms 
available were based on the combined results of two longitudinal studies conducted with 
Swiss children (Iglowstein, et al., 2003). Based on these norms and lofty parent goals, it 
is not surprising that neither Holly nor Keith attained total sleep time goals after the onset 
of treatment. This may be partly because children with ASD tend to sleep less compared 
with typically developing peers (Hodge, Carollo, Lewin, Hoffman, & Sweeney, 2014). 
Compared with other studies with children on the autism spectrum (Durand & Mindell, 
1999; Moon, Corkum, & Smith, 2010; Schreck & Mulick, 2000), Holly’s and Keith’s 
sleep durations appeared to fall within the normal range for their age. Therefore, both 
parent dyads might have overestimated their child’s need for sleep. 
As previously described, two children (Bill and Keith), whose parents had a goal 
of reducing the number of night awakenings, experienced an overall improvement during 
treatment and total elimination during follow-up. These results are consistent with the 
findings of two studies (Piazza, Fisher, and Sherer,1997; DeLeon, Fisher, and Marhefka, 
2004) in that night awakenings were nearly eliminated following BFRC in children with 
ASD. Consistent with findings by Moon, Corkum, and Smith (2010), mean sleep onset 
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latency as measured by both actigraphy and sleep diary revealed an overall decease from 
baseline following BFRC for two children (Bill and Holly) with ASD. BFRC was also 
effective in reducing the duration and frequency of disruptive sleep-related behaviors for 
all three children. Moreover, BFRC produced a clinically significant improvement in 
CSHQ-A total scores for three children with severe ASD.  
Prior to treatment, parent-reported total sleep disturbance scores indicated that 
their children experienced dyssomnia-type sleep problems in the clinical range. Two 
children (Holly and Bill) greatly improved, their problems moving from the clinical range 
to the non-clinical range by the end of follow-up. However, one child (Keith), who 
experienced the greatest improvement with the largest reduction in scores out of all three 
children, was only one point above the clinical cut-off score by the end of the follow-up. 
These parent-reported scores on each subscale are consistent with night-by-night data 
from sleep and behavior diaries, indicating an overall positive change with less bedtime 
resistance for all three children, fewer night awakenings and longer sleep duration for Bill 
and Keith, and less sleep onset delays for Bill. Actigraphy data further support these 
positive changes in sleep onset delays and sleep duration for Bill. These outcomes offer 
strong support for BFRC successfully treating a wide variety of multiple co-occurring 
disruptive sleep and related problem behaviors in children on the autism spectrum.  
The total amount of time spent sleeping in a 24-hour period was greater when 
recorded in sleep diaries vs. by actigraphy across all three children. Furthermore, the 
average amount of time spent in bed as recorded by both sleep diaries and actigraphy 
significantly reduced from baseline to follow-up for all three children. This reduction in 
time spent in bed likely produced the observed improvements in sleep efficiency. 
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According to sleep diary data, each child was already achieving sleep efficiency within 
the low-end of normal (85%) to high (97%) range prior to treatment. However, 
actigraphy data produced lower sleep efficiencies, compared with sleep diary data, for 
each child.  
In contrast to findings by Moon, Corkum, and Smith (2010), there was a pattern 
of change in mean sleep efficiency as measured by actigraphy for two children. Holly’s 
and Bill’s sleep efficiency increased after treatment, and mild improvements were 
maintained at follow-up, whereas Keith’s mean sleep efficiency remained at 89% 
throughout the study. For all three children, the amount of time spent awake after sleep 
onset recorded by actigraphy was greater than time recorded in sleep diaries, which was 
nearly zero. Similarly to the improvements of night awakenings recorded in sleep diaries, 
two of the three children spent no time awake after sleep onset by follow-up, whereas the 
third child might have continued the pattern of zero time awake after initially falling 
asleep had she not experienced a change in routine on the final night of follow-up. 
In the present study, all parent dyads reported high levels of satisfaction with 
BFRC and its results and were willing to strongly recommend this treatment to others. 
This outcome is similar to high parent satisfaction with treatment reported in the one 
other BFRC study that used parents as change agents in the home setting with children 
with ASD (Moon, Corkum, & Smith, 2010). In our study, parents reported the use of 
structured guidelines and the elimination of undesired co-sleeping as being the most 
helpful components. In sum, these parent opinions suggest that benefits outweighed the 
challenges and support the social importance of BFRC as an effective parent-
implemented treatment. Only one parent satisfaction item was rated negatively. This 
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discrepancy might be explained by a change in response item value and topographical 
similarity between Very unconfident and Very confident rather than a true endorsement of 
low confidence in their ability to manage their child’s current problem behaviors. For 
example, these parents wrote, “The treatment was awesome. It gave us the tools we 
needed.” Therefore, this score should be interpreted with caution. As such, this minor 
inconsistency does not diminish the overall high level of parent satisfaction across all 
three families and the social validity of BFRC as a feasible parent-implemented in-home 
treatment for children with ASD and multiple co-occurring sleep problems.  
We explored the impact of changes in sleep problems on marital satisfaction. 
Holly’s parents each experienced some minor improvement in marital satisfaction at the 
end of treatment. This slight improvement does not provide sufficient evidence to support 
the impact of BFRC on marital satisfaction; however, previous findings (Fisman, Wolf, 
& Noh, 1989; Mihaila & Hartley, 2016) suggest various explanations for this change. For 
instance, an increase in martial satisfaction might indicate that Holly’s parents’ sleep also 
improved, thus increasing each parent’s positive affect (Mihaila & Hartley, 2016). 
Likewise, removing Holly from her parents’ bed might have had a positive impact on the 
quality of their marriage by allowing for more time alone with each other (Fisman, Wolf, 
& Noh, 1989). Bill’s and Keith’s parents consistently endorsed being extremely satisfied 
with their marriage, his or her spouse, and his or her relationship with their spouse. 
Although a ceiling effect left little room for improvements in martial relations, these 
results do indicate that BFRC did not produce a decline in couple’s marital satisfaction. 
Piazza, Fisher, and Sherer (1997), DeLeon, Fisher, and Marhefka (2004), and 
Moon, Corkum, and Smith (2010) provided foundational evidence for BFRC as a 
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promising intervention for sleep disturbances experienced by children with ASD. Our 
study expands upon this research in a number of ways. First, the current study addresses 
the lack of agency parents have been given when children participate in treatment-related 
research. Parents, not researchers, determined the treatment goals and the primary 
outcome variables. The current method enhances the social validity of BFRC and the 
social significance of the positive findings. Second, the current study obtained actigraphy 
data as an objective measure of the sleep-related outcome variables.   
Third, a non-concurrent multiple baseline across subjects design was employed in 
place of a more rigorous design due to its feasibility in applied settings and in an attempt 
to avoid potential temporal delays in participant enrollment (Watson & Workman, 1981). 
Nonetheless, we met experimental design requirements (Harvey, May, & Kennedy, 2004) 
by staggering baseline durations across the three participants and planning for the 
implementation of BFRC. For example, BFRC was introduced after baseline data on the 
frequency of the primary target behavior (i.e., undesired co-sleeping) were determined 
stable (4 consecutive days for Holly and 6 consecutive days for Bill) or after 14 
consecutive days of data collection, as done for Keith. The maximum of 14 consecutive 
days represents a potential methodological weakness; however, this two-week limit was 
chosen based on clinical considerations for the participants and their families. 
Experimental control was demonstrated by a functional relationship between the 
implementation of BFRC and observable changes in the frequency of undesired co-
sleeping for each child.  
In addition, results from a small sample might not generalize to a wider 
population. We did not evaluate the extent to which each parent dyad worked together. 
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We did encourage both parents to implement treatment and designated one parent 
responsible for data recording; therefore, it is unclear if a single parent could effectively 
implement treatment and achieve similar results. In addition, this study focused on 
preschool and school-aged children, who largely depend on parents to structure their 
sleep routine and sleep environment. It would be beneficial to determine if parents of 
adolescents with ASD can effectively implement BFRC with comparable outcomes.  
Nevertheless, BFRC was effective for three young children with severe autism and 
multiple co-occurring sleep problems, who were living in a two-parent household. A 
randomized controlled trial would strengthen the external validity of these findings and 
help to determine effective levels of parental participation.  
Lastly, we did not include an objective measure such as video recording to 
confirm procedural integrity or collect IOA to document the reliability of data collection 
procedures. Based on clinical considerations (Burke, Kuhn, & Peterson, 2004; Durand & 
Mindell, 1999; Vollmer & Sloman, 2008), we selected telephone checks, a less intrusive 
method, to ensure ongoing and timely data collection and to obtain data on treatment 
integrity.  
Behavior analysts have a great appreciation for precise terminology that conveys 
information effectively. Response cost is best described as a punishment procedure in the 
form of a penalty, which may not be the most accurate label for the response extinction 
components of the BFRC sleep intervention. Although terminological refinement may be 
warranted, perhaps the more salient endeavor lies in conceptualizing the effectiveness of 
BFRC using behavioral processes and concepts. Respondent conditioning, operant 
conditioning, and the value altering effects of motivating operations all contribute to 
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understanding the socially significant phenomenon of sleep. As such, the process of 
respondent and operant conditioning and motivating operations may all contribute to the 
effectiveness of the BFRC procedure.  
Respondent conditioning may contribute through a stimulus-stimulus pairing 
process, in which an unconditioned stimulus (UCS) becomes a conditioned stimulus (CS) 
that elicits the conditioned response (CR). From a respondent conditioning standpoint, 
the UCS is somnolence (i.e., physiological state of sleepiness), which is often associated 
with delaying bedtime and limiting access to the unconditioned response (UCR) of sleep. 
Delaying the initial bedtime component of the BFRC procedure increases the likelihood 
of the child achieving sleep onset within 15 minutes of being placed in bed. The behavior 
of lying down in bed may have become a CS that functions as a signal for initiating sleep. 
If the child falls asleep soon after being placed in bed, the CS effectively elicited the CR 
of sleep.  
Operant conditioning, that is, the basic process of learning that occurs when a 
stimulus changes immediately following a response, resulting in changes in the behavior 
when under similar conditions in the future, may also contribute to the effectiveness of 
the BFRC procedure. Prior to treatment, the child had access to preferred activities, 
parental attention, and the opportunity to fall asleep whenever he or she became sleepy, 
whereas during treatment the parent controls such accessibility and opportunities. In the 
BFRC treatment, the child has 15 minutes to fall asleep once being placed in bed, 
otherwise he or she is removed from bed and does not have another opportunity to sleep 
for 30 minutes. The stimulus change of being removed from bed occurs immediately 
following the child’s response of being awake in bed. Although the child has access to 
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preferred activities and parental attention, access to sleep is restricted until the next 
scheduled bedtime. As the child’s sleepiness increases, being removed from bed becomes 
an unpleasant event. The child learns to avoid being removed from bed by engaging in 
sleep-compatible behaviors or achieving rapid sleep onset.  
Motivating Operation (MO) is a behavioral concept used to explain variations in 
the strength of value-altering and behavior-altering effects (Michael, 1982; Michael, 
2000). Sleep deprivation is one of the primary MOs identified in humans. It is the current 
strength of sleepiness that can alter the reinforcing value of consequences and change the 
probability of behaviors. That is, extreme sleepiness can increase the effectiveness of 
sleep as reinforcement and increase the current frequency of sleep-compatible behavior 
(e.g., lying down in bed) that has been reinforced by sleep. As such, MOs alter the 
effectiveness of both respondent and operant conditioning. Delaying the child’s bedtime 
and restricting access to sleep alters the reinforcing value of sleep and changes the 
probability of achieving rapid sleep onset and engaging in sleep-compatible behaviors. 
When the duration of time children spend awake in bed is reduced, the experience of 
sleepiness and sleep onset comes under stimulus control of the bedtime routine, the bed, 
and other aspects of the bedroom environment. Therefore, the BFRC procedure makes 
the most out of naturally occurring sleep processes (i.e., motivating operations) while 
teaching more appropriate sleep associations (i.e., stimulus control). 
In summary, this investigation expands research on BFRC as a home-based, 
parent-delivered intervention for undesired co-sleeping with co-occurring sleep problems 
experienced by children with severe ASD. This investigation sets the stage for 
empowering parents to function as the agents of change by utilizing their own treatment 
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goals and making them responsible for implementing BFRC. Moreover, this study 
provides evidence that elevates BFRC toward to a new classification tier as a well 
established empirically supported treatment (Chambless & Hollon, 1998). In conclusion, 
the results of this study provide evidence for parent implementation of BFRC as a 
behavioral treatment option for children with ASD and multiple sleep problems. Future 
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Age in years 8.5 7 4.5 
Gender Female Male Male 
ADOS-2 
     Overall total 
     Comparison score 
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Sleep problems meeting selection criteria 
     Requires parent in room to fall asleep 
     Refusal to sleep in own bed 
     Undesired co-sleeping  
     Bedtime resistance 
     Sleep onset latency 



















Note: An ADOS-2 Comparison score of 6 indicates a moderate level of autism spectrum, 
while a score of 10 indicates a high level of autism spectrum. * Scores for this participant 
were taken from the CARS-2 High Functioning (HF) version, as opposed to the Standard 
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Table 2  
Dependent Variables on Sleep Diary & Sleep Related Behavior Diary 
 
Dependent Sleep Variables Definitions 
Frequency of Night-Awakenings 
(FNA) 
Total number of times child awoke during the 
night and got out of bed; Marked by time with 
an up arrow, not including final rising 
Waking-up After Sleep Onset 
(WASO) 
Total minutes the child is awake after initially 
falling asleep; Non-shaded in boxes of time 
(small box = 15 min.; large box = 1 hour) after 
initial sleep onset, until time of final rising 
Sleep Onset Latency (SOL) The time between initially being placed in bed 
awake, marked by time with a down arrow, and 
the time of sleep onset each night, marked by 
shaded in boxes 
Total Sleep Time (TST) Total duration of nighttime and daytime sleep 
acquired within 24-hours; Shaded in boxes for 
when the child is asleep (small box = 15 min.; 
large box = 1 hour) 
Time in Bed (TIB) Amount of time the child was physically in bed 
during within 24-hours; Time child gets into bed 
marked by a down arrow until final rising 
Dependent Sleep Onset (DSO) The achievement of sleep with the required 
assistance of a parent; Marked by the letter D 
next to a down arrow 
Independent Sleep Onset (ISO) The achievement of sleep without the assistance 
of a parent; Marked by the letter I next to a 
down arrow 
Dependent Sleep Related Behavior 
Variables 
Definitions 
Undesired Co-Sleeping (UC-S) Unwanted co-sleeping with a parent or sibling in 
any room during a 24 hour period; Frequency 
and duration of undesired co-sleeping with 
parent(s) or siblings by child 
Sleeping in a Non-Designated Area Frequency of child sleeping in a location other 
than the child’s bed (e.g., couch, car, floor, etc.) 
during a 24 hour period 
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Session 1: Intake interview, CARS-2, ADOS-2, KMSS, and consent 
Session 2: Identify parent sleep goals, teach data collection, give actigraphy, and 
start baseline data collection 
Session 3: Review week one baseline data and determine treatment or cont. 
baseline 
Session 4: Review week two baseline data or week one treatment data. Cont. or 
discontinue treatment 
Session 5: Review week one or week two of treatment data. Cont. or discontinue 
treatment 
Session 6: Review week two of treatment data or begin follow-up data collection 
(4-weeks post treatment) 
Session 7:  Begin (4-weeks post treatment) or end (7 days) follow-up data 
collection. 
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Table 4  

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Marital Impact Variable, Kansas Marital Satisfaction Scale (KMSS) 
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Sample sleep diary data sheet. 
 
Instructions: Please complete the sleep diary during the evening and morning each day 
within the same 24-hour period. The same person should complete all diaries. Record the 
date and the following information:  
1. Mark the time your child gets into bed with a down arrow “”;  
2. Mark the time your child gets out of bed with an up arrow “”;  
3. Shade in boxes when your child is asleep (small box = 15 minutes; large box = 
1 hour); 4. Mark a “W” next to the arrow if your child was awaken by a parent or 
alarm; mark an “S” if your child awakened by his/herself; and  
5. Mark a “D” if your child falls asleep dependently (with parental presence) or an 





















Sample sleep related behavior diary data sheet. 
 
Instructions: Please complete the sleep related behavior diary during the evening and 
morning each day within the same 24-hour period. The same person should complete all 
diaries. Mark a tally in the corresponding box and record the duration of each instance the 
child engages in a disruptive behavior during the bedtime routine and once placed in bed, 
undesired co-sleeping, and sleep in a non-designated area. Record the date, the time the 
child gets ready for bed, the time and reason for removing the actigraphy, and the 
locations of undesired co-sleeping and non-designated sleep. Please use the following 
definitions: 
1. Disruptive behaviors are defined as one or more verbal protests and/or 
physical protests a night when instructed by a parent to go to bed or go to 
sleep;  
2. Sleeping in a non-designated area is defined as one or more occurrences of 
sleeping in a location other than the child’s bed during a 24 hour period; and 
3. Co-sleeping is defined as unwanted sleeping with a parent or sibling in any 
room during a 24-hour period. 
 




Sample integrity-monitoring data sheet. 
 
Instructions: Record parent responses as reported in the corresponding boxes. Record 
“Y” for “yes”, “N” for “no”, or “N/A” for not applicable to the context.   
Tri-weekly  
phone-check 
1 2 3 4 5 6 7 
Date and time of call  
(e.g., 8/14/13; 8:00am) 
       
Indicate the caller’s 
initials 
       
Parent answer the phone  
(Y, N, or N/A) 
       
Return call by 5:30 p.m. 
(Y, N, or N/A) 
       
Bedtime Fading  
(BF) 
1 2 3 4 5 6 7 
Was BF implemented? 
(Y, N, or N/A) 
       
Time placed child in bed 
last night? 
       
Time checked to see if 
child was sleeping? 
       
How did you determine 
if your child was 
sleeping? 
       
What did you do after 
your child was or was 
not sleeping? 
       
Response cost  
(RC) 
1 2 3 4 5 6 7 
Was RC implemented? 
(Y, N, or N/A) 
       
Time child was taken out 
of bed and bedroom? 
       
What did your child do 
during that time? 
       
Time returned child to 
bed last night? 
       
Time checked to see if 
child was sleeping? 
       
How did you determine 
if your child was 
sleeping? 
       
What did you do after        
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your child was or was 
not sleeping? 
How many times was RC 
repeated? 
       
What time did your child 
finally fall asleep? 
       
 




























Sample vignettes of sleep patterns and related behaviors.  
Please complete the sleep diary and sleep related behavior diary using the information 
presented below. If you have any questions, please do not hesitate to ask the investigator 
before leaving your session.  
 
Vignette 1.   
On Saturday 6/22/13, James went to bed by himself at 9:00 p.m. and fell asleep at
 9:45 p.m., alone. He awoke on his own at 12:30 a.m. and was put back to bed at
 1:45 a.m. by his mother. James fell asleep at 2:00 a.m. by himself and slept till his
 father woke him at 7:30 a.m.. 
 
Vignette 2:   
On Sunday 6/30/13, Chelsea was put to bed by her father at 8:30 p.m. and fell
 asleep at 10 p.m. with her father in the room. Chelsea awoke at 2:30 a.m. and
 went to sleep by herself around 3:30 a.m.. She woke up at 5:00 a.m. on her own,
 but did not leave her bed until 6:00 a.m.. Chelsea fell asleep in the car on the way
 to daycare from 7:30 a.m. till 8:00 a.m. and woke-up independently. On the way
 home from daycare she slept in the car from 5:30 p.m. till her father woke her up

















Sample bedtime fading with response cost treatment protocol.  
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